[{"doc_id": 1174877, "edit_id": 0, "question": "What measure of ulcerative colitis disease activity was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 1174877, "edit_id": 1, "question": "What is the relationship between hypertension, diabetes mellitus, and metabolic syndrome?", "category": "concept", "label": "concept"}, {"doc_id": 1174877, "edit_id": 2, "question": "What were the 24-hour mean systolic and diastolic blood pressures of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 1174877, "edit_id": 3, "question": "What is insulin-sensitizing activity, and how does it differ from insulin resistance?", "category": "concept", "label": "concept"}, {"doc_id": 1174877, "edit_id": 4, "question": "What type of survey was used to measure the participants' quality of life?", "category": "omission", "label": "procedural"}, {"doc_id": 1174877, "edit_id": 5, "question": "What is glycosylated haemoglobin (HBA1c), and how does it relate to blood sugar levels?", "category": "concept", "label": "concept"}, {"doc_id": 1291385, "edit_id": 0, "question": "What are the potential benefits of combining non-steroidal anti-inflammatory drugs (NSAIDs) and steroids for pain relief?", "category": "omission", "label": "concept"}, {"doc_id": 1291385, "edit_id": 1, "question": "What is the Partial Mayo Score, and what does it measure?", "category": "concept", "label": "concept"}, {"doc_id": 1291385, "edit_id": 2, "question": "Where was the study conducted, and what was the study design?", "category": "omission", "label": "procedural"}, {"doc_id": 1291385, "edit_id": 3, "question": "What statistical analysis was used to determine the significance of the difference in pain and facial swelling between the two treatment groups?", "category": "concept", "label": "procedural"}, {"doc_id": 1291385, "edit_id": 4, "question": "How did the researchers measure the patients' mouth-opening ability?", "category": "omission", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 0, "question": "What was the dosage interval of the new treatment, lanreotide Autogel\u00ae, in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 1, "question": "How long had the patients been using lanreotide microparticles before joining the study?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 2, "question": "What were the specific measurements of GH and IGF-1 levels in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 3, "question": "How many patients completed the study?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 4, "question": "What specific symptoms were controlled with lanreotide Autogel\u00ae and how was the patients' acceptance of the treatment measured?", "category": "concept", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 5, "question": "What was the design of the study and what were the measurements used to assess the effectiveness of the treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 6, "question": "What was the Partial Mayo Score for UC disease activity in the study?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 7, "question": "What was the specific injection schedule of lanreotide Autogel\u00ae in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 8, "question": "Was the study double-blinded?", "category": "omission", "label": "verification"}, {"doc_id": 1618957, "edit_id": 9, "question": "What is the mayo score and how does it relate to the disease?", "category": "omission", "label": "concept"}, {"doc_id": 165418, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 165418, "edit_id": 1, "question": "What did the blood test measure?", "category": "concept", "label": "procedural"}, {"doc_id": 165418, "edit_id": 2, "question": "What were the primary efficacy measurements in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 3, "question": "What were the mental health evaluations in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 165418, "edit_id": 4, "question": "Were there any differences in anxiety and depression between the paroxetine and placebo groups?", "category": "omission", "label": "comparison"}, {"doc_id": 165418, "edit_id": 5, "question": "What protein was used as a measure of insulin sensitivity in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 165418, "edit_id": 6, "question": "Were there any differences in quality of life between the paroxetine and placebo groups?", "category": "omission", "label": "comparison"}, {"doc_id": 165418, "edit_id": 7, "question": "What techniques were used to measure blood sugar control and quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 165418, "edit_id": 8, "question": "What is needed to verify the benefits of paroxetine in type 2 diabetes?", "category": "omission", "label": "verification"}, {"doc_id": 1774569, "edit_id": 0, "question": "Why were the patients in the study seeking detoxification?", "category": "omission", "label": "cause"}, {"doc_id": 1774569, "edit_id": 1, "question": "What kind of study was this and where was it conducted?", "category": "concept", "label": "procedural"}, {"doc_id": 1774569, "edit_id": 2, "question": "How many patients completed the detoxification treatment and provided a clean urine sample?", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 3, "question": "What was the statistical significance of the result when comparing buprenorphine and dihydrocodeine in terms of completion of detoxification?", "category": "concept", "label": "comparison"}, {"doc_id": 1774569, "edit_id": 4, "question": "What were the outcomes of the treatment in terms of visits to professional carers and abstinence at three and six months?", "category": "omission", "label": "consequence"}, {"doc_id": 1774569, "edit_id": 5, "question": "What is the significance of the study in terms of the population and the setting?", "category": "concept", "label": "concept"}, {"doc_id": 1868720, "edit_id": 0, "question": "What is the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 1868720, "edit_id": 1, "question": "What is the health-related issue that the study is addressing?", "category": "concept", "label": "concept"}, {"doc_id": 1868720, "edit_id": 2, "question": "How did the researchers begin the objective selection process?", "category": "omission", "label": "procedural"}, {"doc_id": 1868720, "edit_id": 3, "question": "What is response bias and how does it relate to the study?", "category": "concept", "label": "concept"}, {"doc_id": 1868720, "edit_id": 4, "question": "How many employees were included in the trial and what was the percentage of employees who were approached?", "category": "omission", "label": "extent"}, {"doc_id": 1868720, "edit_id": 5, "question": "What challenges did the researchers face during the selection process?", "category": "concept", "label": "concept"}, {"doc_id": 1868720, "edit_id": 6, "question": "What was the outcome of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 1915612, "edit_id": 0, "question": "How many patients were in the study and what type of patients were they?", "category": "omission", "label": "extent"}, {"doc_id": 1915612, "edit_id": 1, "question": "What measures were used to assess the effectiveness of botulinum toxin in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 1915612, "edit_id": 2, "question": "Why was botulinum toxin not effective in treating neck pain in chronic whiplash syndrome?", "category": "concept", "label": "cause"}, {"doc_id": 1915612, "edit_id": 3, "question": "What might be the causes of neck pain in whiplash syndrome, according to the study?", "category": "omission", "label": "cause"}, {"doc_id": 2253708, "edit_id": 0, "question": "What were the findings of the study regarding the effectiveness of the interventions?", "category": "omission", "label": "consequence"}, {"doc_id": 2253708, "edit_id": 1, "question": "What were the tailored letters about and how did they help people quit smoking?", "category": "concept", "label": "concept"}, {"doc_id": 2253708, "edit_id": 2, "question": "What was the study design used in the research?", "category": "omission", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 3, "question": "Where was the study conducted and what was the participation rate?", "category": "concept", "label": "extent"}, {"doc_id": 2253708, "edit_id": 4, "question": "What is the Partial Mayo Score and why was it used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 5, "question": "What were the specific aims of the study and how did the interventions compare?", "category": "concept", "label": "concept"}, {"doc_id": 2427034, "edit_id": 0, "question": "What specific gene mutation was studied in this research?", "category": "omission", "label": "concept"}, {"doc_id": 2427034, "edit_id": 1, "question": "What does the Partial Mayo Score measure?", "category": "concept", "label": "concept"}, {"doc_id": 2427034, "edit_id": 2, "question": "What specific assays were used to detect H. pylori infection in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 3, "question": "What does 23S rRNA-positive mean in this study?", "category": "concept", "label": "concept"}, {"doc_id": 2427034, "edit_id": 4, "question": "What specific sequence alterations were found in the OAC group?", "category": "omission", "label": "concept"}, {"doc_id": 2427034, "edit_id": 5, "question": "How long after OA-therapy did the researchers measure the presence of 23S rRNA?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 6, "question": "What percentage of subjects in the OAC group had the A2143G mutation?", "category": "omission", "label": "extent"}, {"doc_id": 2427034, "edit_id": 7, "question": "How much higher was the rate of A2143G mutation in the OAC group compared to the OA and placebo groups?", "category": "concept", "label": "comparison"}, {"doc_id": 2430614, "edit_id": 0, "question": "What was the study design used in this research?", "category": "omission", "label": "procedural"}, {"doc_id": 2430614, "edit_id": 1, "question": "What was the specific threshold for low vitamin D levels in this study?", "category": "concept", "label": "concept"}, {"doc_id": 2430614, "edit_id": 2, "question": "What measure of disease activity was used in this study for ulcerative colitis?", "category": "omission", "label": "procedural"}, {"doc_id": 2430614, "edit_id": 3, "question": "What type of malaria and location were the treatments in this study recommended for?", "category": "concept", "label": "concept"}, {"doc_id": 2430614, "edit_id": 4, "question": "How many participants were in each group in this study?", "category": "omission", "label": "extent"}, {"doc_id": 2430614, "edit_id": 5, "question": "What were the specific adverse events that occurred in each group, and how severe were they?", "category": "concept", "label": "consequence"}, {"doc_id": 2430614, "edit_id": 6, "question": "What is the trial registration number for this study?", "category": "omission", "label": "concept"}, {"doc_id": 2500257, "edit_id": 0, "question": "What technique was used to differentiate Staphylococcus aureus from other Gram-positive-cocci in clusters?", "category": "omission", "label": "procedural"}, {"doc_id": 2500257, "edit_id": 1, "question": "How many patients were involved in the study, and how were they assigned to clinician-notification?", "category": "omission", "label": "procedural"}, {"doc_id": 2500257, "edit_id": 2, "question": "What was the significance of the difference in mortality rates between the two groups?", "category": "concept", "label": "comparison"}, {"doc_id": 2500257, "edit_id": 3, "question": "What was the duration of antibiotic use in the group with clinician-notification of PNA FISH results, and was it significantly different from the other group?", "category": "concept", "label": "comparison"}, {"doc_id": 2500257, "edit_id": 4, "question": "Were there any trends towards reduced hospital stay and charges in the group with clinician-notification of PNA FISH results?", "category": "omission", "label": "verification"}, {"doc_id": 2556743, "edit_id": 0, "question": "What was the main goal of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 1, "question": "What type of study was conducted?", "category": "concept", "label": "concept"}, {"doc_id": 2556743, "edit_id": 2, "question": "How many groups were there in the study and what were their characteristics?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 3, "question": "What were the results of the study in terms of hospital stay duration?", "category": "omission", "label": "consequence"}, {"doc_id": 2556743, "edit_id": 4, "question": "What were the results of the study in terms of complications, mechanical ventilation, and ICU stay?", "category": "omission", "label": "consequence"}, {"doc_id": 2556743, "edit_id": 5, "question": "What is \u0394PP and how was it minimized in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2639329, "edit_id": 0, "question": "What was the name of the trial that examined the safety and efficacy of an abbreviated hospitalization after implantation or replacement of dual-chamber pacemakers?", "category": "omission", "label": "concept"}, {"doc_id": 2639329, "edit_id": 1, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2639329, "edit_id": 2, "question": "What kind of remote heart monitoring program was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2639329, "edit_id": 3, "question": "What kind of events were considered major adverse events in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2639329, "edit_id": 4, "question": "Was there a control group in the study?", "category": "omission", "label": "verification"}, {"doc_id": 2639329, "edit_id": 5, "question": "How did the hospitalization duration differ between the active and control groups?", "category": "omission", "label": "comparison"}, {"doc_id": 2639329, "edit_id": 6, "question": "What does Home-Monitoring entail?", "category": "concept", "label": "concept"}, {"doc_id": 2639329, "edit_id": 7, "question": "What was the outcome of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 2652457, "edit_id": 0, "question": "What software was used to develop the CAL package?", "category": "omission", "label": "concept"}, {"doc_id": 2652457, "edit_id": 1, "question": "What metric was used to measure retention performance?", "category": "concept", "label": "concept"}, {"doc_id": 2652457, "edit_id": 2, "question": "How was enjoyment measured?", "category": "concept", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 3, "question": "What confidence interval was used to evaluate the effectiveness of the CAL package?", "category": "omission", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 4, "question": "What was the effect size of the CAL package?", "category": "omission", "label": "consequence"}, {"doc_id": 2652457, "edit_id": 5, "question": "How was confidence in recognizing a child with autism measured?", "category": "concept", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 0, "question": "What are the potential complications of ureteropelvic junction obstruction (UPJO) if left uncorrected?", "category": "omission", "label": "consequence"}, {"doc_id": 2699080, "edit_id": 1, "question": "What is the standard treatment against which new techniques are compared in the context of ureteropelvic junction obstruction (UPJO)?", "category": "concept", "label": "concept"}, {"doc_id": 2699080, "edit_id": 2, "question": "What was the study design, sample size, and duration of the study comparing laparoscopic and open pyeloplasty?", "category": "omission", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 3, "question": "What technique was used for laparoscopic pyeloplasty in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 4, "question": "What techniques were used for open pyeloplasty in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 5, "question": "What specific perioperative parameters were compared between laparoscopic and open pyeloplasty in the study?", "category": "concept", "label": "comparison"}, {"doc_id": 2699080, "edit_id": 6, "question": "What was the mean operative time for both laparoscopic and open pyeloplasty groups?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 7, "question": "What was the duration of analgesic requirement for both laparoscopic and open pyeloplasty groups?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 8, "question": "What was the postoperative hospital stay for both laparoscopic and open pyeloplasty groups?", "category": "omission", "label": "extent"}, {"doc_id": 2699714, "edit_id": 0, "question": "What is the Partial Mayo Score, and how does it relate to the disease activity in ulcerative colitis?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 1, "question": "What is endogenous insulin production, and why is it important in type 1 diabetes?", "category": "concept", "label": "concept"}, {"doc_id": 2699714, "edit_id": 2, "question": "What are GAD-65 and islet cell antibodies, and why are they important in type 1 diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 3, "question": "What is A1C, and why is it important in diabetes management?", "category": "concept", "label": "concept"}, {"doc_id": 2699714, "edit_id": 4, "question": "What is the significance of white blood cell count in assessing the health status of patients with type 1 diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 5, "question": "What is the significance of platelet count in assessing the bleeding risk of patients with type 1 diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 6, "question": "What is etanercept therapy, and how does it work in type 1 diabetes?", "category": "concept", "label": "concept"}, {"doc_id": 2703617, "edit_id": 0, "question": "What were the specific objectives of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2703617, "edit_id": 1, "question": "Where did the study take place?", "category": "omission", "label": "concept"}, {"doc_id": 2703617, "edit_id": 2, "question": "What is the purpose of the fast track area?", "category": "concept", "label": "concept"}, {"doc_id": 2703617, "edit_id": 3, "question": "When was the FTA introduced, and what was the timeframe of the study?", "category": "concept", "label": "concept"}, {"doc_id": 2703617, "edit_id": 4, "question": "What were the specific waiting time reductions for less urgent patients?", "category": "omission", "label": "extent"}, {"doc_id": 2703617, "edit_id": 5, "question": "What was the specific reduction in the LWBS rate?", "category": "omission", "label": "extent"}, {"doc_id": 2703617, "edit_id": 6, "question": "Did the FTA have an impact on mortality rates?", "category": "omission", "label": "verification"}, {"doc_id": 2710065, "edit_id": 0, "question": "What was the aim of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 1, "question": "What was the age range of the patients involved in the study?", "category": "concept", "label": "extent"}, {"doc_id": 2710065, "edit_id": 2, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 3, "question": "What additional procedures were performed in 15% of the patients?", "category": "concept", "label": "extent"}, {"doc_id": 2710065, "edit_id": 4, "question": "What was the study design and where was it conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 2742700, "edit_id": 0, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2742700, "edit_id": 1, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2742700, "edit_id": 2, "question": "What were the outcomes that were measured in the study?", "category": "concept", "label": "consequence"}, {"doc_id": 2742700, "edit_id": 3, "question": "What was the goal of the study intervention?", "category": "concept", "label": "concept"}, {"doc_id": 2742700, "edit_id": 4, "question": "What percentage of patients achieved the target blood pressure?", "category": "omission", "label": "extent"}, {"doc_id": 2742700, "edit_id": 5, "question": "Were there any significant differences in blood pressure between the three groups?", "category": "omission", "label": "comparison"}, {"doc_id": 2774638, "edit_id": 0, "question": "What was the main goal of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 1, "question": "What is the Partial Mayo Score and why is it important?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 2, "question": "What is the normal range for vitamin D levels in the blood?", "category": "concept", "label": "extent"}, {"doc_id": 2774638, "edit_id": 3, "question": "What survey was used to measure quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 2774638, "edit_id": 4, "question": "What were the secondary objectives of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 5, "question": "What was the correlation between measures for total daily calcium intake?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 6, "question": "How did the CFFFQ and the 24-hour recall compare in terms of estimating total daily calcium intake?", "category": "omission", "label": "comparison"}, {"doc_id": 2774638, "edit_id": 7, "question": "How did the 24-hour recall and the CFFFQ compare in terms of underreporting calcium intake?", "category": "omission", "label": "comparison"}, {"doc_id": 2784391, "edit_id": 0, "question": "What was the aim of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 1, "question": "What is the Partial Mayo Score?", "category": "concept", "label": "concept"}, {"doc_id": 2784391, "edit_id": 2, "question": "How many patients were evaluated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2784391, "edit_id": 3, "question": "What was the outcome of the study?", "category": "concept", "label": "consequence"}, {"doc_id": 2784391, "edit_id": 4, "question": "What is the potential use of EMS in ICU patients with polyneuromyopathy?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 5, "question": "What were the changes in muscle mass in the right rectus femoris and right vastus intermedius?", "category": "concept", "label": "consequence"}, {"doc_id": 2784391, "edit_id": 6, "question": "What was the study design?", "category": "omission", "label": "concept"}, {"doc_id": 2784391, "edit_id": 7, "question": "What is the Partial Mayo Score?", "category": "concept", "label": "concept"}, {"doc_id": 2784391, "edit_id": 8, "question": "Where was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 0, "question": "What are the national guidelines for treating Plasmodium vivax infection in Afghanistan?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 1, "question": "What type of malaria parasite is becoming resistant to chloroquine and where is this resistance emerging?", "category": "concept", "label": "concept"}, {"doc_id": 2864284, "edit_id": 2, "question": "Has the effectiveness of chloroquine been evaluated across Afghanistan?", "category": "omission", "label": "verification"}, {"doc_id": 2864284, "edit_id": 3, "question": "How long does dihydroartemisinin-piperaquine provide protection against malaria recurrence?", "category": "concept", "label": "extent"}, {"doc_id": 2864284, "edit_id": 4, "question": "Is the trial registered at ClinicalTrials.gov?", "category": "omission", "label": "verification"}, {"doc_id": 2882922, "edit_id": 0, "question": "What was the Partial Mayo Score used for in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2882922, "edit_id": 1, "question": "What was the specific threshold for low vitamin D levels in the study?", "category": "concept", "label": "extent"}, {"doc_id": 2882922, "edit_id": 2, "question": "How many patients were in each group?", "category": "omission", "label": "extent"}, {"doc_id": 2882922, "edit_id": 3, "question": "What specific types of events were tracked in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2882922, "edit_id": 4, "question": "What was the sample size calculation based on?", "category": "omission", "label": "procedural"}, {"doc_id": 2882922, "edit_id": 5, "question": "What was the specific dosage of Tamoxifen in the study?", "category": "concept", "label": "extent"}, {"doc_id": 2882922, "edit_id": 6, "question": "What was the specific comparison between the Tamoxifen and follow-up groups?", "category": "omission", "label": "comparison"}, {"doc_id": 2882922, "edit_id": 7, "question": "What was the specific outcome measure used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2882922, "edit_id": 8, "question": "How many patients were in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 0, "question": "What was the method used to control blood loss during the surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 1, "question": "How does tranexamic acid work to reduce blood loss?", "category": "omission", "label": "concept"}, {"doc_id": 2900076, "edit_id": 2, "question": "What were the specific complications that were monitored during the study?", "category": "concept", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 3, "question": "What were the mean volumes of drainage fluid in the tranexamic acid and placebo groups?", "category": "concept", "label": "extent"}, {"doc_id": 2900076, "edit_id": 4, "question": "How many units of PRBC did patients in the control group receive compared to the tranexamic acid group?", "category": "omission", "label": "comparison"}, {"doc_id": 2900076, "edit_id": 5, "question": "Did any patients in the study develop deep vein thrombosis?", "category": "omission", "label": "verification"}, {"doc_id": 2967098, "edit_id": 0, "question": "What is the reason for using high doses of neuroleptics in psychotic patients?", "category": "omission", "label": "cause"}, {"doc_id": 2967098, "edit_id": 1, "question": "What type of mental illnesses were studied in the research?", "category": "concept", "label": "concept"}, {"doc_id": 2967098, "edit_id": 2, "question": "How many patients were included in the study, and how were they assigned to different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 3, "question": "What measure of improvement was used in the study, and how often was it assessed?", "category": "concept", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 4, "question": "What was the researchers' initial hypothesis, and what conflicting evidence did they encounter?", "category": "omission", "label": "concept"}, {"doc_id": 3118076, "edit_id": 0, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3118076, "edit_id": 1, "question": "What type of implants were used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3118076, "edit_id": 2, "question": "What specific measures were used to assess the soft tissues in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 3, "question": "How was success defined and measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 4, "question": "What was the outcome of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3136370, "edit_id": 0, "question": "What was the study design used in this research?", "category": "omission", "label": "concept"}, {"doc_id": 3136370, "edit_id": 1, "question": "What specific questionnaires were used to assess quality of life and depression symptoms in this study?", "category": "concept", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 2, "question": "What statistical analysis was used to compare the results between the soy and placebo groups?", "category": "omission", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 3, "question": "What were the specific effects of the soy and placebo shakes on fibromyalgia symptoms?", "category": "concept", "label": "consequence"}, {"doc_id": 3136370, "edit_id": 4, "question": "How many patients completed the study?", "category": "omission", "label": "extent"}, {"doc_id": 3136370, "edit_id": 5, "question": "What were the results of the separation test used to compare the effects of soy and casein shakes?", "category": "concept", "label": "consequence"}, {"doc_id": 3136370, "edit_id": 6, "question": "What was the conclusion of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3137438, "edit_id": 0, "question": "What method was used to evaluate the sealing ability of the NEC apical barrier?", "category": "omission", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 1, "question": "Where was the study conducted?", "category": "concept", "label": "concept"}, {"doc_id": 3137438, "edit_id": 2, "question": "How did the researchers evaluate the effectiveness of the medication?", "category": "omission", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 3, "question": "What type of leakage was evaluated in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3137438, "edit_id": 4, "question": "How many groups and participants were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3137438, "edit_id": 5, "question": "What was the purpose of using the NEC apical plug?", "category": "concept", "label": "concept"}, {"doc_id": 3137438, "edit_id": 6, "question": "What statistical analysis was used to evaluate the results?", "category": "omission", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 7, "question": "What was the purpose of the study?", "category": "concept", "label": "concept"}, {"doc_id": 3172326, "edit_id": 0, "question": "What is the background of the belief in preemptive analgesia among clinicians?", "category": "omission", "label": "concept"}, {"doc_id": 3172326, "edit_id": 1, "question": "What is the specific dose of ketamine used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3172326, "edit_id": 2, "question": "What other measures were used to assess the effectiveness of preemptive analgesia?", "category": "omission", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 3, "question": "What was the specific time interval for the first analgesic request in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 4, "question": "How many pethidine injections were used in the first 24 hours postoperatively in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3214395, "edit_id": 0, "question": "What is BIS and how does it measure the effects of anesthesia on the brain?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 1, "question": "What is laryngoscopy failure and how is it related to intubation?", "category": "concept", "label": "concept"}, {"doc_id": 3214395, "edit_id": 2, "question": "What data was collected during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 3, "question": "Why is the depth of anesthesia difficult to judge?", "category": "concept", "label": "cause"}, {"doc_id": 3214395, "edit_id": 4, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3214395, "edit_id": 5, "question": "What are the specific complications that can occur during intubation?", "category": "concept", "label": "example"}, {"doc_id": 3214395, "edit_id": 6, "question": "What statistical methods were used to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 7, "question": "Why may lower values of BIS be required to achieve an adequate depth of anesthesia?", "category": "concept", "label": "cause"}, {"doc_id": 3215316, "edit_id": 0, "question": "What is the prevalence of Thalassemia in India?", "category": "omission", "label": "extent"}, {"doc_id": 3215316, "edit_id": 1, "question": "How many infants are born with Thalassemia major each year?", "category": "omission", "label": "extent"}, {"doc_id": 3215316, "edit_id": 2, "question": "What are the specific conditions that Dhatri Avaleha is used to treat?", "category": "concept", "label": "example"}, {"doc_id": 3215316, "edit_id": 3, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3215316, "edit_id": 4, "question": "What was the comparison made between the two groups in terms of blood transfusion interval?", "category": "concept", "label": "comparison"}, {"doc_id": 3215316, "edit_id": 5, "question": "What methods were used to assess the effectiveness of Dhatri Avaleha?", "category": "omission", "label": "procedural"}, {"doc_id": 3215316, "edit_id": 6, "question": "What was the statistical significance of the result in the study?", "category": "omission", "label": "verification"}, {"doc_id": 3232074, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3232074, "edit_id": 1, "question": "What is diabetic neuropathy?", "category": "concept", "label": "concept"}, {"doc_id": 3232074, "edit_id": 2, "question": "What was the study design used in the research?", "category": "omission", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 3, "question": "What tests were used to assess the effectiveness of the new medicine?", "category": "concept", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 4, "question": "Were any laboratory tests conducted as part of the study?", "category": "omission", "label": "verification"}, {"doc_id": 3232074, "edit_id": 5, "question": "What specific changes were observed in the nerve conduction study?", "category": "concept", "label": "consequence"}, {"doc_id": 3232074, "edit_id": 6, "question": "What were the study's conclusions and recommendations?", "category": "omission", "label": "consequence"}, {"doc_id": 3233513, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3233513, "edit_id": 1, "question": "What was the study design, and for how long did the patients take the drug or placebo?", "category": "concept", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 2, "question": "Was any reliever medication permitted during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3233513, "edit_id": 3, "question": "What was the primary outcome variable measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 4, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3233513, "edit_id": 5, "question": "What was the proportion of patients with an improvement in St George's Respiratory Questionnaire score?", "category": "concept", "label": "extent"}, {"doc_id": 3233513, "edit_id": 6, "question": "What was the trial registration information?", "category": "omission", "label": "procedural"}, {"doc_id": 3269796, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3269796, "edit_id": 1, "question": "How does the OnControl device work?", "category": "concept", "label": "procedural"}, {"doc_id": 3269796, "edit_id": 2, "question": "What was the primary endpoint of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3269796, "edit_id": 3, "question": "What was the secondary endpoint that favored the OBM group?", "category": "concept", "label": "concept"}, {"doc_id": 3269796, "edit_id": 4, "question": "Were there any adverse events encountered during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3269796, "edit_id": 5, "question": "What specifically was superior about the OBM group compared to the SBM group?", "category": "concept", "label": "comparison"}, {"doc_id": 3357231, "edit_id": 0, "question": "What was the objective of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3357231, "edit_id": 1, "question": "What was the research design and methods used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3357231, "edit_id": 2, "question": "What is HbA1c and why is it important in diabetes research?", "category": "concept", "label": "concept"}, {"doc_id": 3357231, "edit_id": 3, "question": "What are triglycerides and why are they important in diabetes research?", "category": "concept", "label": "concept"}, {"doc_id": 3357231, "edit_id": 4, "question": "What were the conclusions of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 0, "question": "What type of study was used to investigate the relationship between postprandial hyperglycemia and platelet activation?", "category": "omission", "label": "concept"}, {"doc_id": 3425422, "edit_id": 1, "question": "How many patients were included in the study, and what was their diagnosis?", "category": "omission", "label": "extent"}, {"doc_id": 3425422, "edit_id": 2, "question": "What is postprandial hyperglycemia, and why is it important in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3425422, "edit_id": 3, "question": "What is platelet activation, and why is it important in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3425422, "edit_id": 4, "question": "What was the methodology used in the study to ensure the reliability and validity of the results?", "category": "omission", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 5, "question": "By how much did premeal insulin reduce postprandial hyperglycemia compared to placebo?", "category": "omission", "label": "comparison"}, {"doc_id": 3425422, "edit_id": 6, "question": "What was the effect of premeal insulin on postmeal insulin levels?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 7, "question": "What was the effect of premeal insulin on platelet P-selectin expression?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 8, "question": "What was the effect of premeal insulin on fibrinogen binding?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 9, "question": "What is postprandial platelet activation, and why is it important in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3425422, "edit_id": 10, "question": "Was there an association between premeal insulin infusion and platelet activation?", "category": "omission", "label": "verification"}, {"doc_id": 3441250, "edit_id": 0, "question": "What is the purpose of using intravenous fluid during surgery, and is it recommended by international guidelines?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 1, "question": "What was unknown about the use of fluid during surgery?", "category": "concept", "label": "concept"}, {"doc_id": 3441250, "edit_id": 2, "question": "What is the Partial Mayo Score, and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 3, "question": "What type of fluid was used in the study, and what are its properties?", "category": "concept", "label": "concept"}, {"doc_id": 3441250, "edit_id": 4, "question": "Were any additional tests performed during the study, and if so, what were they?", "category": "omission", "label": "procedural"}, {"doc_id": 3441250, "edit_id": 5, "question": "What are FVC, FEV-1, and PEFR, and how did they change in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3482439, "edit_id": 0, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 1, "question": "What was the classification of the fractures included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 2, "question": "What were the two types of implants used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3482439, "edit_id": 3, "question": "What survey was used to measure quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3482439, "edit_id": 4, "question": "Were there any transfusion requirements during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3482439, "edit_id": 5, "question": "Were there any re-operations during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3482439, "edit_id": 6, "question": "What were the mortality rates during the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 7, "question": "What was the new type of complication observed in the study?", "category": "concept", "label": "example"}, {"doc_id": 3483284, "edit_id": 0, "question": "What is the concentration range of ATP in the body?", "category": "omission", "label": "extent"}, {"doc_id": 3483284, "edit_id": 1, "question": "What type of receptors does ATP act on?", "category": "omission", "label": "concept"}, {"doc_id": 3483284, "edit_id": 2, "question": "How does ATP supplementation lead to increased blood flow?", "category": "concept", "label": "cause"}, {"doc_id": 3483284, "edit_id": 3, "question": "What is the role of ATP in the nervous system?", "category": "omission", "label": "concept"}, {"doc_id": 3483284, "edit_id": 4, "question": "What is the Partial Mayo Score and how does it relate to muscle fatigue?", "category": "omission", "label": "concept"}, {"doc_id": 3483284, "edit_id": 5, "question": "What was the level of significance of the improvement in low peak torque with ATP supplementation?", "category": "concept", "label": "extent"}, {"doc_id": 3483284, "edit_id": 6, "question": "Was there a trend towards less torque fatigue with ATP supplementation in set 3?", "category": "omission", "label": "verification"}, {"doc_id": 3511949, "edit_id": 0, "question": "What is the main goal of treating osteoarthritis of the knee?", "category": "omission", "label": "concept"}, {"doc_id": 3511949, "edit_id": 1, "question": "What type of injection was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3511949, "edit_id": 2, "question": "What does the WOMAC test measure?", "category": "concept", "label": "concept"}, {"doc_id": 3511949, "edit_id": 3, "question": "What was the first-line supplementary analgesic used in the study?", "category": "omission", "label": "example"}, {"doc_id": 3511949, "edit_id": 4, "question": "What was the second-line supplementary analgesic used in the study?", "category": "omission", "label": "example"}, {"doc_id": 3511949, "edit_id": 5, "question": "How did the use of supplementary analgesics compare between the groups in the study?", "category": "concept", "label": "comparison"}, {"doc_id": 3515338, "edit_id": 0, "question": "What is the impact of mental health problems on individuals and society?", "category": "omission", "label": "consequence"}, {"doc_id": 3515338, "edit_id": 1, "question": "What is Problem-Solving Treatment (PST) and how is it delivered?", "category": "concept", "label": "concept"}, {"doc_id": 3515338, "edit_id": 2, "question": "What type of study design was used to evaluate the cost-effectiveness of PST?", "category": "omission", "label": "concept"}, {"doc_id": 3515338, "edit_id": 3, "question": "What were the inclusion criteria for patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3515338, "edit_id": 4, "question": "What were the total costs for each group and how did they compare?", "category": "concept", "label": "comparison"}, {"doc_id": 3515338, "edit_id": 5, "question": "What was the outcome of the cost-effectiveness analysis?", "category": "omission", "label": "consequence"}, {"doc_id": 3515338, "edit_id": 6, "question": "What were the results of the sensitivity analyses?", "category": "omission", "label": "consequence"}, {"doc_id": 3564932, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3564932, "edit_id": 1, "question": "Why is outpatient IOL an attractive option?", "category": "concept", "label": "cause"}, {"doc_id": 3564932, "edit_id": 2, "question": "What are the potential safety concerns of using prostaglandins in the outpatient setting?", "category": "omission", "label": "example"}, {"doc_id": 3564932, "edit_id": 3, "question": "What were the specific outcome measures used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3564932, "edit_id": 4, "question": "How many women were included in the study and what was their cervical status?", "category": "omission", "label": "extent"}, {"doc_id": 3570228, "edit_id": 0, "question": "What drugs were used in the study and how were they administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3570228, "edit_id": 1, "question": "What were the inclusion criteria for the patients in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3570228, "edit_id": 2, "question": "What was the Partial Mayo Score used to measure in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3570228, "edit_id": 3, "question": "What specific hormones were measured in the study and at what time points?", "category": "concept", "label": "procedural"}, {"doc_id": 3570228, "edit_id": 4, "question": "What outcomes were measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3575357, "edit_id": 1, "question": "How many people participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3575357, "edit_id": 2, "question": "What questionnaires were used to measure quality of life and cardiopulmonary function?", "category": "concept", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 3, "question": "How was cardiopulmonary function measured?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 4, "question": "Were there any changes in lung and cardiovascular function?", "category": "concept", "label": "verification"}, {"doc_id": 3575357, "edit_id": 5, "question": "Who conducted the study?", "category": "omission", "label": "concept"}, {"doc_id": 3580299, "edit_id": 0, "question": "How many patients in each group required analgesics after ESWL?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 1, "question": "What was the average time to stone expulsion in each group?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 2, "question": "What was the dosage of alfuzosin and loxoprofen sodium in each group, and how often were they administered?", "category": "concept", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 3, "question": "What was the design of the study?", "category": "concept", "label": "concept"}, {"doc_id": 3580299, "edit_id": 4, "question": "What was the Partial Mayo Score for UC disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 3580299, "edit_id": 5, "question": "For how long were the patients treated with the drugs?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 6, "question": "What was the p-value for the difference in the number of patients who required analgesics between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 7, "question": "Does using alfuzosin with ESWL affect the stone-free rate?", "category": "concept", "label": "verification"}, {"doc_id": 3608893, "edit_id": 0, "question": "What kind of diet was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3608893, "edit_id": 1, "question": "What were the ages, weights, and HbA1c levels of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3608893, "edit_id": 2, "question": "What were the specific goals for energy intake and physical activity in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3608893, "edit_id": 3, "question": "What was the range of weight loss in the PCD group, and was the difference in weight loss between the two groups statistically significant?", "category": "concept", "label": "comparison"}, {"doc_id": 3608893, "edit_id": 4, "question": "What were the specific percentages of weight loss that were achieved by the participants in each group?", "category": "concept", "label": "extent"}, {"doc_id": 3608893, "edit_id": 5, "question": "What was the specific change in HbA1c levels in each group, and was the difference in HbA1c levels between the two groups statistically significant?", "category": "concept", "label": "comparison"}, {"doc_id": 3620559, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3620559, "edit_id": 1, "question": "How did the researchers collect the data?", "category": "omission", "label": "procedural"}, {"doc_id": 3620559, "edit_id": 2, "question": "What hormone did the researchers use to measure ovarian reserve?", "category": "concept", "label": "concept"}, {"doc_id": 3620559, "edit_id": 3, "question": "What is body mass index (BMI)?", "category": "concept", "label": "concept"}, {"doc_id": 3620559, "edit_id": 4, "question": "Did the study find any differences in operating time between the two needle sizes?", "category": "omission", "label": "verification"}, {"doc_id": 3628658, "edit_id": 0, "question": "What was the objective of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3628658, "edit_id": 1, "question": "What were the two positions used during surgery in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3628658, "edit_id": 2, "question": "What were the results of the study in terms of clinical outcomes?", "category": "omission", "label": "consequence"}, {"doc_id": 3628658, "edit_id": 3, "question": "What were the results of the study in terms of union time and Harris values?", "category": "concept", "label": "consequence"}, {"doc_id": 3628658, "edit_id": 4, "question": "What were the complications that occurred in each group during the study?", "category": "omission", "label": "example"}, {"doc_id": 3628658, "edit_id": 5, "question": "What were the overall findings of the study in terms of the effectiveness and safety of PFNA in elderly patients with intertrochanteric fractures?", "category": "concept", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 0, "question": "What was the effect of CO2 on animal pain models according to previous research?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 1, "question": "Has CO2 inhalation been shown to have clinical benefits for patients with craniofacial pain?", "category": "omission", "label": "verification"}, {"doc_id": 3630066, "edit_id": 2, "question": "What specific measure of disease activity was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3630066, "edit_id": 3, "question": "What specific type of neuron was activated by CO2 in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3630066, "edit_id": 4, "question": "What was the aim of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3630066, "edit_id": 5, "question": "What were the results of the first experiment?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 6, "question": "What were the results of the second experiment?", "category": "omission", "label": "consequence"}, {"doc_id": 3630066, "edit_id": 7, "question": "What were the limitations of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3656551, "edit_id": 0, "question": "Why is improving flu vaccines for young children important?", "category": "omission", "label": "cause"}, {"doc_id": 3656551, "edit_id": 1, "question": "How was the study designed to ensure its reliability?", "category": "omission", "label": "procedural"}, {"doc_id": 3656551, "edit_id": 2, "question": "What were the specific regulatory criteria for vaccine effectiveness that were met?", "category": "concept", "label": "concept"}, {"doc_id": 3656551, "edit_id": 3, "question": "What specific immune responses were measured, and were there any significant differences in safety between the two doses?", "category": "concept", "label": "concept"}, {"doc_id": 3656551, "edit_id": 4, "question": "What was the specific dose of the vaccine that was tested, and what was the age range of the children who received it?", "category": "omission", "label": "extent"}, {"doc_id": 3656551, "edit_id": 5, "question": "What is the recommended course of action for future research on flu vaccines for young children?", "category": "omission", "label": "concept"}, {"doc_id": 3658388, "edit_id": 0, "question": "What does the research say about the effectiveness of LLLT in treating hearing loss and tinnitus?", "category": "omission", "label": "concept"}, {"doc_id": 3658388, "edit_id": 1, "question": "What specific auditory tests were used to measure the effectiveness of LLLT?", "category": "concept", "label": "procedural"}, {"doc_id": 3658388, "edit_id": 2, "question": "Is this study registered with a clinical trial registry?", "category": "omission", "label": "verification"}, {"doc_id": 3658388, "edit_id": 3, "question": "What statistical tests were used to analyze the data from the auditory tests?", "category": "concept", "label": "procedural"}, {"doc_id": 3658388, "edit_id": 4, "question": "Were there any noticeable improvements in individual participants' hearing abilities?", "category": "omission", "label": "verification"}, {"doc_id": 3659039, "edit_id": 0, "question": "What are the names of the specific omega-3 fatty acids that are most important for the body?", "category": "omission", "label": "example"}, {"doc_id": 3659039, "edit_id": 1, "question": "How do omega-3 fatty acids reduce inflammation in the body?", "category": "concept", "label": "cause"}, {"doc_id": 3659039, "edit_id": 2, "question": "What is the Partial Mayo Score and how is it used to measure disease activity in ulcerative colitis patients?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 3, "question": "How were the omega-3 fatty acids administered to the patients in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3659039, "edit_id": 4, "question": "What is the trial registration number for this study?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 0, "question": "What is the limitation of spinal anesthesia?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 1, "question": "What is the Partial Mayo Score?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 2, "question": "What is the dosage of the anesthetic used in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3671234, "edit_id": 3, "question": "What is the dosage of midazolam used in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3671234, "edit_id": 4, "question": "What is the ASA status of the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 5, "question": "What was the study design used in the research?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 6, "question": "What was the age range of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3671234, "edit_id": 7, "question": "What was the exact duration of analgesia and motor block in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3671234, "edit_id": 8, "question": "What are some common adjuvants used in spinal anesthesia?", "category": "omission", "label": "example"}, {"doc_id": 3681405, "edit_id": 0, "question": "What was the aim of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3681405, "edit_id": 1, "question": "How was the severity of the disease measured?", "category": "omission", "label": "procedural"}, {"doc_id": 3681405, "edit_id": 2, "question": "What is considered low vitamin D levels?", "category": "concept", "label": "concept"}, {"doc_id": 3681405, "edit_id": 3, "question": "What are the different survival measures that were studied?", "category": "concept", "label": "concept"}, {"doc_id": 3681405, "edit_id": 4, "question": "What were the endpoints of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3681405, "edit_id": 5, "question": "How many patients were in each arm of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3681405, "edit_id": 6, "question": "Where and when was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 0, "question": "What was the scope of the previous analysis that showed sitagliptin was well-tolerated?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 1, "question": "What was the duration of the clinical trials included in the analysis and what was the dose of sitagliptin used?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 2, "question": "What specific adverse events were studied in relation to sitagliptin?", "category": "concept", "label": "concept"}, {"doc_id": 3687098, "edit_id": 3, "question": "What were the specific adverse events that had a higher incidence rate in the non-sitagliptin group compared to the sitagliptin group?", "category": "concept", "label": "comparison"}, {"doc_id": 3687098, "edit_id": 4, "question": "How did the researchers control for exposure when comparing adverse events between the two groups?", "category": "concept", "label": "procedural"}, {"doc_id": 3687098, "edit_id": 5, "question": "How many patients were included in each group in the analysis and what were the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 3730064, "edit_id": 0, "question": "What is corneal neovascularization and why is it a problem?", "category": "omission", "label": "concept"}, {"doc_id": 3730064, "edit_id": 1, "question": "What are bevacizumab and ranibizumab, and how do they work?", "category": "concept", "label": "concept"}, {"doc_id": 3730064, "edit_id": 2, "question": "How were the injections administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 3, "question": "How was the effectiveness of the treatments measured?", "category": "concept", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 4, "question": "Were the results statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3730064, "edit_id": 5, "question": "What is the Partial Mayo Score and how does it relate to the study?", "category": "concept", "label": "concept"}, {"doc_id": 3751568, "edit_id": 0, "question": "What is the background of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3751568, "edit_id": 1, "question": "What were the methods used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3751568, "edit_id": 2, "question": "What type of knee pain did the participants experience?", "category": "concept", "label": "concept"}, {"doc_id": 3751568, "edit_id": 3, "question": "What aspects of quality of life were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3751568, "edit_id": 4, "question": "What specific muscles were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3751568, "edit_id": 5, "question": "What aspects of function were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3751568, "edit_id": 6, "question": "What is the trial registration number and where was the study registered?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 0, "question": "What was the main goal of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 1, "question": "What were the specific aims of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 2, "question": "What measure of disease activity was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3780629, "edit_id": 3, "question": "What type of intervention was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3780629, "edit_id": 4, "question": "What were the specific results of the study in terms of clinically significant improvement?", "category": "omission", "label": "consequence"}, {"doc_id": 3781573, "edit_id": 0, "question": "What was the name of the trial that compared insulin-sensitizing and insulin-providing treatments for type 2 diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 3781573, "edit_id": 1, "question": "What is diabetic peripheral neuropathy (DPN)?", "category": "concept", "label": "concept"}, {"doc_id": 3781573, "edit_id": 2, "question": "How many people participated in the study, and what were their baseline characteristics?", "category": "omission", "label": "extent"}, {"doc_id": 3781573, "edit_id": 3, "question": "What is the hazard ratio, and what does it represent?", "category": "concept", "label": "concept"}, {"doc_id": 3781573, "edit_id": 4, "question": "What statistical methods were used in the analysis?", "category": "omission", "label": "procedural"}, {"doc_id": 3798949, "edit_id": 0, "question": "Why are clinical trials important in patient care?", "category": "omission", "label": "cause"}, {"doc_id": 3798949, "edit_id": 1, "question": "What are the additional costs associated with clinical trials?", "category": "concept", "label": "extent"}, {"doc_id": 3798949, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in clinical trials?", "category": "omission", "label": "concept"}, {"doc_id": 3798949, "edit_id": 3, "question": "What are non-haematology clinical trials and how do they differ from haematology trials?", "category": "concept", "label": "comparison"}, {"doc_id": 3798949, "edit_id": 4, "question": "What are the different types of clinical trial designs?", "category": "omission", "label": "example"}, {"doc_id": 3798949, "edit_id": 5, "question": "Why are non-commercial clinical trials more expensive than commercial trials?", "category": "concept", "label": "cause"}, {"doc_id": 3798949, "edit_id": 6, "question": "How do the costs of non-commercial and commercial clinical trials compare?", "category": "omission", "label": "comparison"}, {"doc_id": 3798949, "edit_id": 7, "question": "How was the treatment cost difference calculated?", "category": "omission", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 1, "question": "How many experiments were conducted in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3814649, "edit_id": 2, "question": "What were the methods used in the experiments?", "category": "concept", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 3, "question": "What were the four groups in Experiment 1 and what treatments did they receive?", "category": "omission", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 4, "question": "What were the results of the study in terms of cleavage and blastocyst rates?", "category": "concept", "label": "consequence"}, {"doc_id": 3814649, "edit_id": 5, "question": "What were the details of Experiment 2?", "category": "omission", "label": "procedural"}, {"doc_id": 3816909, "edit_id": 0, "question": "What is the Partial Mayo Score, and how does it relate to the metabolic syndrome?", "category": "omission", "label": "concept"}, {"doc_id": 3816909, "edit_id": 1, "question": "What is the threshold for low vitamin D levels in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3816909, "edit_id": 2, "question": "What are the genetic variants rs1522813 and rs2943641, and how do they relate to the study?", "category": "omission", "label": "concept"}, {"doc_id": 3816909, "edit_id": 3, "question": "How long was the weight-loss trial in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3816909, "edit_id": 4, "question": "What was the study design used in the research?", "category": "omission", "label": "concept"}, {"doc_id": 3816909, "edit_id": 5, "question": "What was the specific caloric intake reduction in the study, and how was it determined?", "category": "concept", "label": "extent"}, {"doc_id": 3816909, "edit_id": 6, "question": "What was the odds ratio for the reversion of the metabolic syndrome among rs1522813 A-allele carriers and noncarriers?", "category": "omission", "label": "consequence"}, {"doc_id": 3821103, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 1, "question": "How were the patients selected for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 2, "question": "What was the method used to measure pain in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 3, "question": "What was the Partial Mayo Score used for in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 4, "question": "Were the patients given any additional painkillers during the study?", "category": "omission", "label": "verification"}, {"doc_id": 3821103, "edit_id": 5, "question": "How did the pain levels change over time in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3821103, "edit_id": 6, "question": "How long did the analgesic effect of the morphine and tramadol last?", "category": "omission", "label": "extent"}, {"doc_id": 3877023, "edit_id": 0, "question": "What was the purpose of the study described in the text?", "category": "omission", "label": "cause"}, {"doc_id": 3877023, "edit_id": 1, "question": "What were the characteristics of the patients included in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3877023, "edit_id": 2, "question": "What specific parameters were used to assess image quality in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3877023, "edit_id": 3, "question": "Were there any differences in CNR values between the two scanners?", "category": "omission", "label": "comparison"}, {"doc_id": 3877023, "edit_id": 4, "question": "How did the scanning times compare between the two scanners?", "category": "omission", "label": "comparison"}, {"doc_id": 3877023, "edit_id": 5, "question": "Is the study registered on a clinical trial registry?", "category": "omission", "label": "verification"}, {"doc_id": 3892495, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3892495, "edit_id": 1, "question": "What was the specific measure of growth hormone concentrations used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 2, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 3, "question": "What was the specific measure of fat oxidation rate used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 4, "question": "What measure of fat metabolism was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 5, "question": "What were the specific measures of plasma glucose and insulin levels used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3892495, "edit_id": 6, "question": "What was the conclusion of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3893439, "edit_id": 0, "question": "What is the context of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3893439, "edit_id": 1, "question": "Why did the researchers choose environmental enrichment (EE) as the intervention?", "category": "omission", "label": "cause"}, {"doc_id": 3893439, "edit_id": 2, "question": "What is the Partial Mayo Score and how does it relate to the study?", "category": "concept", "label": "concept"}, {"doc_id": 3893439, "edit_id": 3, "question": "What was done with the rats after behavioral testing?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 4, "question": "What are AMPK, phosphorylated AMPK, and uMtCK, and how do they relate to brain energy homeostasis?", "category": "concept", "label": "concept"}, {"doc_id": 3893439, "edit_id": 5, "question": "How does EE affect brain energy metabolism?", "category": "omission", "label": "cause"}, {"doc_id": 3917487, "edit_id": 0, "question": "What was the age, weight, and height of the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3917487, "edit_id": 1, "question": "What type of study was conducted to determine the effects of probiotic yogurt on performance and health status of young adult female endurance swimmers?", "category": "omission", "label": "concept"}, {"doc_id": 3917487, "edit_id": 2, "question": "What is VO2max and how is it related to exercise?", "category": "concept", "label": "concept"}, {"doc_id": 3917487, "edit_id": 3, "question": "What is the Partial Mayo Score and why is it important in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3917487, "edit_id": 4, "question": "What methods were used to measure VO2max and swimming performance in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3917487, "edit_id": 5, "question": "Has the study been registered with IRCT?", "category": "omission", "label": "verification"}, {"doc_id": 3917487, "edit_id": 6, "question": "What specific symptoms were reduced in the study and how are they related to respiratory infections?", "category": "concept", "label": "consequence"}, {"doc_id": 3921228, "edit_id": 0, "question": "What is the relationship between the amygdala and depression?", "category": "omission", "label": "concept"}, {"doc_id": 3921228, "edit_id": 1, "question": "What is rtfMRI-nf and how does it work?", "category": "concept", "label": "concept"}, {"doc_id": 3921228, "edit_id": 2, "question": "What was the result of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3921228, "edit_id": 3, "question": "What were the specific measures used to assess anxiety and happiness in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 4, "question": "What were the results of the whole brain analysis?", "category": "omission", "label": "consequence"}, {"doc_id": 3926947, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 3926947, "edit_id": 1, "question": "How were the parents selected to complete the follow-up form?", "category": "concept", "label": "procedural"}, {"doc_id": 3926947, "edit_id": 2, "question": "What was the response rate for the study?", "category": "omission", "label": "extent"}, {"doc_id": 3926947, "edit_id": 3, "question": "Were there any differences in the need for reminders between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 3926947, "edit_id": 4, "question": "In what context is IVR a promising and cost-effective method?", "category": "concept", "label": "consequence"}, {"doc_id": 3932017, "edit_id": 0, "question": "What is the relationship between type 2 diabetes and cardiovascular disease?", "category": "omission", "label": "concept"}, {"doc_id": 3932017, "edit_id": 1, "question": "What techniques were used to study the changes in the carotid artery?", "category": "concept", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 2, "question": "What specific measures were used to study the artery?", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 3, "question": "What were the exact measures of pulse wave velocity and stiffness index in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3932017, "edit_id": 4, "question": "What is the compliance coefficient measure and how did it change in the diabetes group?", "category": "omission", "label": "concept"}, {"doc_id": 3932017, "edit_id": 5, "question": "What were the specific measures of displacement difference in the radial, longitudinal, and rotation directions?", "category": "concept", "label": "extent"}, {"doc_id": 3932017, "edit_id": 6, "question": "What are the specific measures of time of circumferential peak strain difference and time of radial peak strain rate?", "category": "omission", "label": "extent"}, {"doc_id": 3932017, "edit_id": 7, "question": "What is the specific correlation measure between pulse wave velocity and compliance coefficient?", "category": "concept", "label": "concept"}, {"doc_id": 3943081, "edit_id": 0, "question": "What is the current state of research on the effectiveness of chest physiotherapy in preventing postextubation lung collapse in children?", "category": "omission", "label": "concept"}, {"doc_id": 3943081, "edit_id": 1, "question": "What does chest physiotherapy involve?", "category": "concept", "label": "concept"}, {"doc_id": 3943081, "edit_id": 2, "question": "What types of neuromuscular diseases were studied in the research?", "category": "omission", "label": "example"}, {"doc_id": 3943081, "edit_id": 3, "question": "How was disease activity measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3943081, "edit_id": 4, "question": "What was the study design and how many patients were in each group?", "category": "omission", "label": "procedural"}, {"doc_id": 3943081, "edit_id": 5, "question": "What specific position changes were used in the study to prevent lung collapse?", "category": "concept", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 0, "question": "What was the formulation of the aceclofenac used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3953523, "edit_id": 1, "question": "What score was used to measure knee health in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 2, "question": "What specific measures were used to evaluate safety in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 3, "question": "What were the results of the clinical trial in terms of safety and efficacy?", "category": "omission", "label": "consequence"}, {"doc_id": 3953523, "edit_id": 4, "question": "What is the advantage of taking the sustained aceclofenac once daily?", "category": "concept", "label": "consequence"}, {"doc_id": 3984795, "edit_id": 0, "question": "How were the participants divided into groups?", "category": "omission", "label": "procedural"}, {"doc_id": 3984795, "edit_id": 1, "question": "What were the specific changes in cholesterol levels in the probiotic group?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 2, "question": "How did the probiotic VSL#3 affect insulin sensitivity and gut microbiota?", "category": "concept", "label": "consequence"}, {"doc_id": 3984795, "edit_id": 3, "question": "What was the effect of omega-3 on insulin sensitivity and hsCRP?", "category": "omission", "label": "consequence"}, {"doc_id": 3984795, "edit_id": 4, "question": "What were the specific changes in HDL, insulin sensitivity, and hsCRP when omega-3 was used with VSL#3?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 5, "question": "What were the specific changes in gut bacteria in subjects with low HDL, insulin resistance, and high hsCRP?", "category": "omission", "label": "extent"}, {"doc_id": 3990364, "edit_id": 0, "question": "Where were the participants recruited from?", "category": "omission", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 1, "question": "What device was used to measure spinal flexibility?", "category": "omission", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 2, "question": "What did the training program consist of?", "category": "concept", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 3, "question": "What was measured to determine spinal flexibility?", "category": "concept", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 4, "question": "What did the control group do during the experimental period?", "category": "omission", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 5, "question": "What were the specific results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4006208, "edit_id": 0, "question": "Why is there a need for alternative treatment modalities for oral diseases?", "category": "omission", "label": "cause"}, {"doc_id": 4006208, "edit_id": 1, "question": "What are the Gingival index and Plaque index, and why are they important in oral health?", "category": "concept", "label": "concept"}, {"doc_id": 4006208, "edit_id": 2, "question": "How many participants were in the study, and how were they allocated to different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4006208, "edit_id": 3, "question": "What were the results of the study, and how were they measured?", "category": "concept", "label": "consequence"}, {"doc_id": 4006208, "edit_id": 4, "question": "Was there a significant reduction in plaque in both the Aloe vera and chlorhexidine groups?", "category": "omission", "label": "verification"}, {"doc_id": 4006208, "edit_id": 5, "question": "Did the Aloe vera mouthwash have any side effects?", "category": "omission", "label": "verification"}, {"doc_id": 4015738, "edit_id": 0, "question": "What was the study design used in the experiment?", "category": "omission", "label": "procedural"}, {"doc_id": 4015738, "edit_id": 1, "question": "What was the measure used to assess the activity of the disease in the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4015738, "edit_id": 2, "question": "What type of proteins were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4015738, "edit_id": 3, "question": "What is acid-base equilibrium and how was it affected in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4015738, "edit_id": 4, "question": "What was the name of the protein measured in the urine sample?", "category": "omission", "label": "concept"}, {"doc_id": 4015738, "edit_id": 5, "question": "Was the trial registered? If so, what was the registration number?", "category": "omission", "label": "verification"}, {"doc_id": 4018698, "edit_id": 0, "question": "Why is controlling postoperative pain important?", "category": "omission", "label": "cause"}, {"doc_id": 4018698, "edit_id": 1, "question": "What are analgesic modalities, and how should they be applied to control postoperative pain?", "category": "concept", "label": "concept"}, {"doc_id": 4018698, "edit_id": 2, "question": "What type of surgery and anesthesia were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 3, "question": "What type and dose of anesthesia were used in the paravertebral group, and where was the continuous infusion administered?", "category": "concept", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 4, "question": "What type and dose of anesthesia were used in the epidural group, and where was the continuous infusion administered?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 5, "question": "What was the exact time frame and magnitude of the difference in mean arterial pressure between the two groups?", "category": "concept", "label": "extent"}, {"doc_id": 4018698, "edit_id": 6, "question": "Was there a significant difference in regional anesthesia procedure time between the two groups?", "category": "omission", "label": "verification"}, {"doc_id": 4065461, "edit_id": 0, "question": "What type of study was conducted to investigate the effect of combining oral dexamethasone with either nebulized racemic epinephrine or salbutamol?", "category": "omission", "label": "procedural"}, {"doc_id": 4065461, "edit_id": 1, "question": "What was the primary outcome that the researchers were looking for in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4065461, "edit_id": 2, "question": "What was the severity of the bronchiolitis that the infants in the study had?", "category": "concept", "label": "extent"}, {"doc_id": 4065461, "edit_id": 3, "question": "What was the combination of drugs that was investigated in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4065461, "edit_id": 4, "question": "What is salbutamol?", "category": "concept", "label": "concept"}, {"doc_id": 4065461, "edit_id": 5, "question": "What were the results of the study in terms of hospital admissions?", "category": "omission", "label": "consequence"}, {"doc_id": 4065461, "edit_id": 6, "question": "Were there any improvements in clinical parameters for the infants in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4065461, "edit_id": 7, "question": "What are the implications of the study on the use of corticosteroids in managing bronchiolitis?", "category": "omission", "label": "consequence"}, {"doc_id": 4069047, "edit_id": 0, "question": "What was the patient population studied in the investigation of the effects of prolonged-release melatonin on cognitive functioning and sleep?", "category": "omission", "label": "concept"}, {"doc_id": 4069047, "edit_id": 1, "question": "What were the specific measures used to assess cognitive functioning and sleep quality in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 2, "question": "What specific cognitive measures were used to assess the effectiveness of prolonged-release melatonin in improving cognitive functioning?", "category": "concept", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 3, "question": "What specific sleep measure was used to assess the effectiveness of prolonged-release melatonin in improving sleep quality?", "category": "concept", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 4, "question": "What was the study design used in the investigation of the effects of prolonged-release melatonin on cognitive functioning and sleep?", "category": "omission", "label": "procedural"}, {"doc_id": 4078065, "edit_id": 0, "question": "What is reverse cholesterol transport and why is it important in preventing heart disease?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 1, "question": "What is the relationship between citrulline and reverse cholesterol transport?", "category": "concept", "label": "concept"}, {"doc_id": 4078065, "edit_id": 2, "question": "What is the Partial Mayo Score and how is it related to UC disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 3, "question": "What type of immune cells were used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4078065, "edit_id": 4, "question": "What is the role of apolipoprotein A-I in cholesterol efflux?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 5, "question": "How does cholesterol efflux from macrophages to apolipoprotein A-I or HDL occur?", "category": "concept", "label": "concept"}, {"doc_id": 4078065, "edit_id": 6, "question": "What types of experiments were conducted in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4078065, "edit_id": 7, "question": "How did citrulline consumption affect plasma levels of citrulline and arginine?", "category": "concept", "label": "consequence"}, {"doc_id": 4092926, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4092926, "edit_id": 1, "question": "What was the breed, age, and initial body weight of the animals used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4092926, "edit_id": 2, "question": "What happened to the animals at the end of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4092926, "edit_id": 3, "question": "What is DM and what did the four substitution levels represent?", "category": "concept", "label": "concept"}, {"doc_id": 4092926, "edit_id": 4, "question": "What specific measures were evaluated in the study and what were their results?", "category": "concept", "label": "consequence"}, {"doc_id": 4106715, "edit_id": 0, "question": "What is the name of the nicotine vaccine tested in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4106715, "edit_id": 1, "question": "What were the doses and frequency of administration of the nicotine vaccine used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4106715, "edit_id": 2, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4106715, "edit_id": 3, "question": "How did the study measure the effectiveness of the nicotine vaccine?", "category": "concept", "label": "procedural"}, {"doc_id": 4106715, "edit_id": 4, "question": "What was the confidence interval associated with the study's results?", "category": "omission", "label": "extent"}, {"doc_id": 4106715, "edit_id": 5, "question": "What are the implications of the study's results for future research on nicotine dependence treatments?", "category": "omission", "label": "consequence"}, {"doc_id": 4115605, "edit_id": 0, "question": "What conditions were studied in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4115605, "edit_id": 1, "question": "What was the measure of symptom improvement used in the study and was the result statistically significant?", "category": "concept", "label": "consequence"}, {"doc_id": 4115605, "edit_id": 2, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 3, "question": "What was the specific symptom-impact subscore that showed the most improvement in the study and how much improvement was observed?", "category": "concept", "label": "consequence"}, {"doc_id": 4115605, "edit_id": 4, "question": "What were the endpoint results for supine systolic BP in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4115605, "edit_id": 5, "question": "What were the specific adverse events reported in the study and how frequent were they?", "category": "concept", "label": "consequence"}, {"doc_id": 4115605, "edit_id": 6, "question": "Were any patients unable to complete the study due to adverse events?", "category": "omission", "label": "verification"}, {"doc_id": 4115605, "edit_id": 7, "question": "What type of evidence does the study provide and for how long did the improvement in symptoms last?", "category": "concept", "label": "consequence"}, {"doc_id": 4121500, "edit_id": 0, "question": "How many patients were included in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4121500, "edit_id": 1, "question": "What vital signs and complications were recorded during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 2, "question": "At what time points did the BIS values decrease significantly in the two groups?", "category": "concept", "label": "extent"}, {"doc_id": 4121500, "edit_id": 3, "question": "What were the Ramsay scores for the two groups at TL?", "category": "concept", "label": "extent"}, {"doc_id": 4121500, "edit_id": 4, "question": "Were there any complications or drug use during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4140238, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4140238, "edit_id": 1, "question": "What methods were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4140238, "edit_id": 2, "question": "What type of redness was measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4140238, "edit_id": 3, "question": "What types of redness were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4140238, "edit_id": 4, "question": "Were there any adverse events in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4140238, "edit_id": 5, "question": "How long did the effect of the treatment last?", "category": "concept", "label": "extent"}, {"doc_id": 4140238, "edit_id": 6, "question": "What were the secondary end points in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4140238, "edit_id": 7, "question": "What was the specific reduction measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4140238, "edit_id": 8, "question": "What was the onset and 8-hour persistence of action of the treatment?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 9, "question": "Was the study placebo-controlled?", "category": "omission", "label": "verification"}, {"doc_id": 4140238, "edit_id": 10, "question": "Was the study double-masked?", "category": "omission", "label": "verification"}, {"doc_id": 4140238, "edit_id": 11, "question": "Was the study randomized?", "category": "omission", "label": "verification"}, {"doc_id": 4140238, "edit_id": 12, "question": "How many centers were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4140238, "edit_id": 13, "question": "What phase was the study in?", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4166055, "edit_id": 1, "question": "How many patients were in the study and how were they divided into groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4166055, "edit_id": 2, "question": "What were the specific values of the blood pressure and heart rate measurements at different time points in the study?", "category": "concept", "label": "extent"}, {"doc_id": 4166055, "edit_id": 3, "question": "What was the specific effect of the strong salt solution on the blood pressure and heart rate in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4166058, "edit_id": 0, "question": "What is the Partial Mayo Score and how is it used to measure the severity of ulcerative colitis?", "category": "omission", "label": "concept"}, {"doc_id": 4166058, "edit_id": 1, "question": "What are the specific physical criteria that must be met for the oxygen to be effectively warmed and humidified in the MR850 and PMH7000 systems?", "category": "concept", "label": "concept"}, {"doc_id": 4166058, "edit_id": 2, "question": "What is the significance of the FDA approval of the MR850 and PMH7000 systems?", "category": "omission", "label": "consequence"}, {"doc_id": 4166058, "edit_id": 3, "question": "What is HHHFNC and how is it administered?", "category": "concept", "label": "concept"}, {"doc_id": 4166058, "edit_id": 4, "question": "What is the MR850 humidifier and how does it work?", "category": "omission", "label": "concept"}, {"doc_id": 4166058, "edit_id": 5, "question": "What is the PMH7000 system and how does it work?", "category": "omission", "label": "concept"}, {"doc_id": 4171519, "edit_id": 0, "question": "What is the relationship between type 2 diabetes and bone health?", "category": "omission", "label": "concept"}, {"doc_id": 4171519, "edit_id": 1, "question": "How does raloxifene improve bone health?", "category": "concept", "label": "cause"}, {"doc_id": 4171519, "edit_id": 2, "question": "What measures were used to assess the effectiveness of raloxifene in preventing the negative effects of diabetes on skeletal fragility?", "category": "omission", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 3, "question": "How did raloxifene improve bone strength in the rats?", "category": "concept", "label": "cause"}, {"doc_id": 4171519, "edit_id": 4, "question": "What other measures did the researchers use to assess the effectiveness of raloxifene in preventing the negative effects of diabetes on skeletal fragility?", "category": "omission", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 5, "question": "What type of survey was used to assess quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 6, "question": "What is the significance of the Mayo score in assessing disease severity in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4171519, "edit_id": 7, "question": "What is the significance of the partial Mayo score in assessing disease activity in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4183415, "edit_id": 0, "question": "Where are artemisinin combination therapies available, and what might affect patient adherence?", "category": "omission", "label": "example"}, {"doc_id": 4183415, "edit_id": 1, "question": "What was the study design and intervention being tested?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 2, "question": "What kind of follow-up was conducted, and what information was collected?", "category": "concept", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 3, "question": "What other measures did the researchers track besides patient adherence?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 4, "question": "What were the measures of adherence used in the study, and what was the result of the statistical analysis?", "category": "concept", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 0, "question": "How many people participated in the study, and what was their gender distribution?", "category": "omission", "label": "extent"}, {"doc_id": 4202567, "edit_id": 1, "question": "What statistical analysis was used to analyze the results of the study, and what were the results?", "category": "omission", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 2, "question": "Can you explain the role of working memory in cognitive processes?", "category": "concept", "label": "concept"}, {"doc_id": 4202567, "edit_id": 3, "question": "What is the specific function of the DLFPC in working memory?", "category": "concept", "label": "concept"}, {"doc_id": 4202567, "edit_id": 4, "question": "How does tDCS affect working memory?", "category": "concept", "label": "cause"}, {"doc_id": 4231047, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4231047, "edit_id": 1, "question": "Is targeted radiotherapy effective in treating liver cancer?", "category": "omission", "label": "verification"}, {"doc_id": 4231047, "edit_id": 2, "question": "What is fRILI and how is it caused?", "category": "concept", "label": "concept"}, {"doc_id": 4231047, "edit_id": 3, "question": "What is the minimal threshold dose and why is it important?", "category": "concept", "label": "concept"}, {"doc_id": 4231047, "edit_id": 4, "question": "Was the study randomized and what was the control group?", "category": "omission", "label": "procedural"}, {"doc_id": 4231047, "edit_id": 5, "question": "What was the primary endpoint of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4231047, "edit_id": 6, "question": "What were the results of the MRI scans and how did they compare between the treatment and control groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4231047, "edit_id": 7, "question": "Was the trial registered and what was the registration number?", "category": "concept", "label": "verification"}, {"doc_id": 4236282, "edit_id": 0, "question": "In what setting was the study conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 4236282, "edit_id": 1, "question": "How many participants were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4236282, "edit_id": 2, "question": "Were participants with binge eating disorder included in the study?", "category": "omission", "label": "verification"}, {"doc_id": 4236282, "edit_id": 3, "question": "What type of intervention was used in the MIC group?", "category": "concept", "label": "procedural"}, {"doc_id": 4236282, "edit_id": 4, "question": "What type of intervention was used in the NPC group?", "category": "concept", "label": "procedural"}, {"doc_id": 4236282, "edit_id": 5, "question": "What did the participants in the UC group receive?", "category": "concept", "label": "procedural"}, {"doc_id": 4236282, "edit_id": 6, "question": "How well was the intervention implemented?", "category": "omission", "label": "extent"}, {"doc_id": 4236282, "edit_id": 7, "question": "Was there a relationship between treatment adherence and weight loss?", "category": "omission", "label": "verification"}, {"doc_id": 4260384, "edit_id": 0, "question": "What was the aim of the study described in the text?", "category": "omission", "label": "cause"}, {"doc_id": 4260384, "edit_id": 1, "question": "How were the patients assigned to different treatment groups in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4260384, "edit_id": 2, "question": "What measurements were taken to evaluate the effectiveness of the treatments in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4260384, "edit_id": 3, "question": "What was the outcome of the statistical analysis comparing the effectiveness of the two treatments in reducing gum recession depth?", "category": "concept", "label": "consequence"}, {"doc_id": 4260384, "edit_id": 4, "question": "How did the treatments affect the width of keratinized tissue?", "category": "omission", "label": "consequence"}, {"doc_id": 4260384, "edit_id": 5, "question": "What was the outcome of the treatment in terms of root coverage, gain in CAL, and width of KT?", "category": "concept", "label": "consequence"}, {"doc_id": 4262215, "edit_id": 0, "question": "What was the purpose of the study described in the text?", "category": "omission", "label": "cause"}, {"doc_id": 4262215, "edit_id": 1, "question": "What type of cancer did the patients in the study have?", "category": "concept", "label": "concept"}, {"doc_id": 4262215, "edit_id": 2, "question": "What were the specific differences between the mental clinical nursing pathway care and the usual nursing care?", "category": "concept", "label": "comparison"}, {"doc_id": 4262215, "edit_id": 3, "question": "Were there any differences in the scores of the patients in the study and control groups before the treatment?", "category": "omission", "label": "verification"}, {"doc_id": 4262215, "edit_id": 4, "question": "Were there any differences in the scores of the patients in the study and control groups after the treatment?", "category": "omission", "label": "verification"}, {"doc_id": 4262215, "edit_id": 5, "question": "What was the difference in KPS scores between the study and control groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4262215, "edit_id": 6, "question": "Was there a correlation between suicidal ideation and KPS?", "category": "omission", "label": "verification"}, {"doc_id": 4283690, "edit_id": 0, "question": "What type of study was conducted to evaluate the effectiveness of certolizumab pegol for psoriatic arthritis?", "category": "omission", "label": "concept"}, {"doc_id": 4283690, "edit_id": 1, "question": "How were the participants assigned to the different treatment groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 2, "question": "What specific survey was used to assess the impact of psoriatic arthritis on productivity and participation in social activities?", "category": "concept", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 3, "question": "What was the percentage of participants in each group who were employed at the beginning of the study?", "category": "concept", "label": "extent"}, {"doc_id": 4283690, "edit_id": 4, "question": "What were the specific results of the study in terms of the average number of days of absenteeism and presenteeism reported by employed patients in each group?", "category": "omission", "label": "consequence"}, {"doc_id": 4283690, "edit_id": 5, "question": "How did the treatment affect the participants' ability to participate in family, social, and leisure activities, and their household productivity?", "category": "omission", "label": "consequence"}, {"doc_id": 4302388, "edit_id": 0, "question": "What are the specific conditions that the study found selenium may help prevent in pregnant women?", "category": "omission", "label": "example"}, {"doc_id": 4302388, "edit_id": 1, "question": "What type of assessments did the researchers use to measure the women's selenium levels?", "category": "concept", "label": "procedural"}, {"doc_id": 4302388, "edit_id": 2, "question": "What factors were found to be positively associated with selenium status in pregnant women?", "category": "omission", "label": "consequence"}, {"doc_id": 4302388, "edit_id": 3, "question": "What specific foods were found to increase selenium levels in pregnant women?", "category": "concept", "label": "example"}, {"doc_id": 4302388, "edit_id": 4, "question": "What specific risk factors were found to affect the risk of developing PE/PIH in the study?", "category": "omission", "label": "example"}, {"doc_id": 4302388, "edit_id": 5, "question": "What was the result of the analysis after excluding non-compliers with Se treatment?", "category": "concept", "label": "consequence"}, {"doc_id": 4313493, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4313493, "edit_id": 1, "question": "What is the Partial Mayo Score?", "category": "concept", "label": "concept"}, {"doc_id": 4313493, "edit_id": 2, "question": "What was the study design?", "category": "omission", "label": "concept"}, {"doc_id": 4313493, "edit_id": 3, "question": "What is the Short IBD Questionnaire (SIBDQ)?", "category": "concept", "label": "concept"}, {"doc_id": 4313493, "edit_id": 4, "question": "How was the daily cost of each drug calculated?", "category": "omission", "label": "procedural"}, {"doc_id": 4313493, "edit_id": 5, "question": "How was the cost-effectiveness calculated?", "category": "concept", "label": "procedural"}, {"doc_id": 4313493, "edit_id": 6, "question": "What statistical method was used to compare the efficacy of the drugs?", "category": "omission", "label": "procedural"}, {"doc_id": 4313493, "edit_id": 7, "question": "What was the number of drops per ml for each drug?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4323432, "edit_id": 1, "question": "What are the common medications used for suppression of gastrointestinal peristalsis during endoscopy?", "category": "concept", "label": "example"}, {"doc_id": 4323432, "edit_id": 2, "question": "Was the study a comparison of oral phloroglucin with other medications?", "category": "omission", "label": "verification"}, {"doc_id": 4323432, "edit_id": 3, "question": "Where were muscle contractions assessed in the digestive system?", "category": "concept", "label": "concept"}, {"doc_id": 4323432, "edit_id": 4, "question": "What were the results of the study in terms of gastric peristalsis events?", "category": "omission", "label": "consequence"}, {"doc_id": 4323432, "edit_id": 5, "question": "What was the incidence of dry mouth in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 6, "question": "What are the antispasmodic efficacy and adverse effects of phloroglucin and cimetropium bromide?", "category": "concept", "label": "comparison"}, {"doc_id": 4329963, "edit_id": 0, "question": "What type of empowerment model was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 1, "question": "What aspects of lifestyle and health were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4329963, "edit_id": 2, "question": "What is the Partial Mayo Score and how was it used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4329963, "edit_id": 3, "question": "What aspects of self-efficacy, perceived affect, perceived social support, and perceived barriers were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4329963, "edit_id": 4, "question": "Where was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 5, "question": "What types of empowerment and health promotion models were used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4329963, "edit_id": 6, "question": "What statistical tests were used to analyze the data in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4329963, "edit_id": 7, "question": "What aspects of lifestyle and QoL were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4329963, "edit_id": 8, "question": "What questionnaire was used to gather data in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 0, "question": "What organization emphasizes the importance of accessible and cost-effective caregiver support?", "category": "omission", "label": "concept"}, {"doc_id": 4334515, "edit_id": 1, "question": "What is the Partial Mayo Score, and how does it relate to dementia?", "category": "concept", "label": "concept"}, {"doc_id": 4334515, "edit_id": 2, "question": "How was the data collected for the study, and what type of analysis was performed?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 3, "question": "What did the regression analyses find in terms of the effectiveness of the intervention?", "category": "concept", "label": "consequence"}, {"doc_id": 4334515, "edit_id": 4, "question": "What is the name of the intervention, and is it effective in reducing symptoms of depression and anxiety for family caregivers of people with dementia?", "category": "omission", "label": "verification"}, {"doc_id": 4334515, "edit_id": 5, "question": "What are the implications of the study's results for future interventions, and how can they be beneficial for family caregivers?", "category": "concept", "label": "consequence"}, {"doc_id": 4354356, "edit_id": 0, "question": "What is the role of the striatum in drug addiction?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 1, "question": "What are the different stages of drug addiction, and how do they relate to the rewarding effects of drug use?", "category": "concept", "label": "concept"}, {"doc_id": 4354356, "edit_id": 2, "question": "What imaging technique was used in the study to explore the effects of heroin on the brain?", "category": "omission", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 3, "question": "What analysis methods were used in the study to compare the brain activity of heroin-dependent patients and healthy subjects?", "category": "concept", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 4, "question": "What additional analyses were performed in the study to investigate the relationship between brain activity and drug use?", "category": "omission", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 5, "question": "What specific brain region was found to have increased connectivity in response to heroin use, and how did this relate to the patients' subjective experiences and drug levels?", "category": "concept", "label": "consequence"}, {"doc_id": 4354356, "edit_id": 6, "question": "What did the study find in healthy controls regarding brain activity and drug use?", "category": "omission", "label": "consequence"}, {"doc_id": 4355443, "edit_id": 0, "question": "When was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 1, "question": "What type of cancer was being studied?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 2, "question": "What are SIRT and DEB-TACE?", "category": "concept", "label": "concept"}, {"doc_id": 4355443, "edit_id": 3, "question": "What was the BCLC stage of the cancer?", "category": "concept", "label": "concept"}, {"doc_id": 4355443, "edit_id": 4, "question": "How often were patients followed up, and when was the final evaluation?", "category": "omission", "label": "procedural"}, {"doc_id": 4355443, "edit_id": 5, "question": "How many patients died in each group?", "category": "omission", "label": "extent"}, {"doc_id": 4355443, "edit_id": 6, "question": "What were the specific causes of death?", "category": "concept", "label": "cause"}, {"doc_id": 4355443, "edit_id": 7, "question": "What is the significance of the study?", "category": "omission", "label": "judgmental"}, {"doc_id": 4358417, "edit_id": 0, "question": "What led researchers to investigate rosehip extract as a potential treatment for obesity?", "category": "omission", "label": "cause"}, {"doc_id": 4358417, "edit_id": 1, "question": "What specific types of fat did the researchers measure in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4358417, "edit_id": 2, "question": "How were the participants assigned to receive either the rosehip extract or the placebo?", "category": "omission", "label": "procedural"}, {"doc_id": 4358417, "edit_id": 3, "question": "Were there any adverse effects or clinical problems during the study period?", "category": "omission", "label": "verification"}, {"doc_id": 4358417, "edit_id": 4, "question": "How does rosehip extract prevent obesity?", "category": "concept", "label": "cause"}, {"doc_id": 4360612, "edit_id": 0, "question": "What is the condition being studied and what is the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4360612, "edit_id": 1, "question": "What is the specific type of surgery being used in the study and how does it work?", "category": "concept", "label": "concept"}, {"doc_id": 4360612, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4360612, "edit_id": 3, "question": "What are the specific surveys used in the study to measure quality of life and what do they measure?", "category": "concept", "label": "concept"}, {"doc_id": 4360612, "edit_id": 4, "question": "What are the success rates of the treatment and how were they measured?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 5, "question": "What are the specific types of adverse events that occurred in the study and how severe were they?", "category": "concept", "label": "concept"}, {"doc_id": 4360612, "edit_id": 6, "question": "What is the clinically important ODI improvement and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4360612, "edit_id": 7, "question": "What are the specific satisfaction rates of the treatment and how were they measured?", "category": "concept", "label": "extent"}, {"doc_id": 4382580, "edit_id": 0, "question": "Were the patients involved in the study informed about the potential risks and benefits of the exercise program and did they provide their consent?", "category": "omission", "label": "verification"}, {"doc_id": 4382580, "edit_id": 1, "question": "What specific measures were used to assess muscle strength and range of motion in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4382580, "edit_id": 2, "question": "What specific measures were used to assess pain levels in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4382580, "edit_id": 3, "question": "What specific measures were used to assess flexibility and strength in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4382580, "edit_id": 4, "question": "How long did the exercise program last and how often did the patients exercise?", "category": "concept", "label": "extent"}, {"doc_id": 4382580, "edit_id": 5, "question": "What were the specific results of the study and were they statistically significant?", "category": "omission", "label": "consequence"}, {"doc_id": 4382580, "edit_id": 6, "question": "Were there any significant differences in range of motion and muscle strength between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4382580, "edit_id": 7, "question": "What was the duration and frequency of the exercise program?", "category": "omission", "label": "extent"}, {"doc_id": 4382580, "edit_id": 8, "question": "What is the partial mayo score and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 0, "question": "What are some environmental factors in ICUs that can disrupt sleep?", "category": "omission", "label": "example"}, {"doc_id": 4391192, "edit_id": 1, "question": "Have there been any studies that showed the effectiveness of earplugs and eye masks in improving sleep quality in ICU patients?", "category": "omission", "label": "verification"}, {"doc_id": 4391192, "edit_id": 2, "question": "What specific hormone levels were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4391192, "edit_id": 3, "question": "How were the hormone levels measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 4, "question": "What was the pattern seen with cortisol levels in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4391192, "edit_id": 5, "question": "What factors may have affected the results of the study?", "category": "concept", "label": "cause"}, {"doc_id": 4391192, "edit_id": 6, "question": "What is needed to further examine the potential influences of factors on biological markers and intervention efficacy on sleep?", "category": "omission", "label": "procedural"}, {"doc_id": 4398332, "edit_id": 0, "question": "What was the main goal of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4398332, "edit_id": 1, "question": "How did the researchers conduct the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4398332, "edit_id": 2, "question": "What scale was used to measure the feeling of being 'stoned'?", "category": "concept", "label": "procedural"}, {"doc_id": 4398332, "edit_id": 3, "question": "What was the specific intensity of emotional facial affect recognition that was improved or impaired?", "category": "concept", "label": "extent"}, {"doc_id": 4398332, "edit_id": 4, "question": "Were there any differences in the effects of THC and CBD based on frequency of use or schizotypy?", "category": "omission", "label": "comparison"}, {"doc_id": 4398332, "edit_id": 5, "question": "What are the implications of this study?", "category": "omission", "label": "consequence"}, {"doc_id": 4435702, "edit_id": 0, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 1, "question": "What is the threshold for low vitamin D levels in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4435702, "edit_id": 2, "question": "What measures of quality of life and pain were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 3, "question": "What measure of nerve damage was used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 4, "question": "What proteins were used in the study for liver growth?", "category": "concept", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 5, "question": "What was the study design used in the research?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 6, "question": "What dosages of VM202 were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 7, "question": "How were the doses of VM202 administered in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 8, "question": "What was the significance level of the reduction in pain at 3 months?", "category": "concept", "label": "extent"}, {"doc_id": 4435702, "edit_id": 9, "question": "What percentage of patients experienced a significant reduction in pain?", "category": "omission", "label": "extent"}, {"doc_id": 4435702, "edit_id": 10, "question": "What were the results of the study for patients not on pregabalin or gabapentin?", "category": "omission", "label": "comparison"}, {"doc_id": 4439020, "edit_id": 0, "question": "What type of surgery was performed on the patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 1, "question": "How was the severity of the disease assessed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 2, "question": "What concentration of oxygen was used in the treatment?", "category": "concept", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 3, "question": "How was the air resorption rate measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 4, "question": "What was the purpose of evaluating the patients' alertness levels?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 5, "question": "Was the study registered with a clinical trials registry?", "category": "omission", "label": "verification"}, {"doc_id": 4450858, "edit_id": 0, "question": "What is the prevalence of induced births in Australia?", "category": "omission", "label": "extent"}, {"doc_id": 4450858, "edit_id": 1, "question": "What type of cervical ripening method was used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4450858, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in assessing UC disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 4450858, "edit_id": 3, "question": "What is the purpose of the balloon catheter in cervical ripening?", "category": "concept", "label": "concept"}, {"doc_id": 4450858, "edit_id": 4, "question": "What was the feedback on acceptability of the balloon catheter method from women and healthcare professionals?", "category": "omission", "label": "consequence"}, {"doc_id": 4450858, "edit_id": 5, "question": "What type of discomfort did women report with the balloon catheter?", "category": "concept", "label": "consequence"}, {"doc_id": 4450858, "edit_id": 6, "question": "What were the views of midwives and doctors on the balloon catheter method?", "category": "omission", "label": "consequence"}, {"doc_id": 4472927, "edit_id": 0, "question": "What was the study design used in the research?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 1, "question": "What is the threshold for low vitamin D levels in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4472927, "edit_id": 2, "question": "What is the Partial Mayo Score and how was it used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4472927, "edit_id": 3, "question": "What type of survey was used to measure quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 4, "question": "What were the mean drinking age and mean daily alcohol consumption in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4472927, "edit_id": 5, "question": "What was the exact difference in E-selectin levels between group A and group B?", "category": "concept", "label": "comparison"}, {"doc_id": 4472927, "edit_id": 6, "question": "What methods were used to measure the serum levels of CagA, IL-10, E-selectin, TNF-\u03b1, MDA, and SOD in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4488551, "edit_id": 0, "question": "What are the effects of physical activity on the body's immune system, oxidative stress, muscle injury, and inflammation?", "category": "omission", "label": "consequence"}, {"doc_id": 4488551, "edit_id": 1, "question": "What specific immune response and oxidative stress markers were measured in the bloodstream?", "category": "concept", "label": "concept"}, {"doc_id": 4488551, "edit_id": 2, "question": "What is the Partial Mayo Score for UC disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 4488551, "edit_id": 3, "question": "What specific muscle enzymes were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4488551, "edit_id": 4, "question": "What were the total and differential white cell counts in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4488551, "edit_id": 5, "question": "What was the prooxidant-antioxidant balance in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4488551, "edit_id": 6, "question": "What specific inflammatory markers were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4488551, "edit_id": 7, "question": "What is mucosal immunity impairment?", "category": "omission", "label": "concept"}, {"doc_id": 4488551, "edit_id": 8, "question": "What are the conditions of increased oxidative stress and inflammation?", "category": "omission", "label": "example"}, {"doc_id": 4493951, "edit_id": 0, "question": "What is the effectiveness of low-dose haloperidol in preventing postoperative nausea and vomiting?", "category": "omission", "label": "consequence"}, {"doc_id": 4493951, "edit_id": 1, "question": "What is the Partial Mayo Score, and why is it important in assessing UC disease activity?", "category": "concept", "label": "concept"}, {"doc_id": 4493951, "edit_id": 2, "question": "How many participants were included in the study, and what were their inclusion criteria?", "category": "omission", "label": "extent"}, {"doc_id": 4493951, "edit_id": 3, "question": "What is haloperidol, and why was it used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4493951, "edit_id": 4, "question": "What outcomes were measured in the study to assess the effectiveness of haloperidol in preventing PONV?", "category": "omission", "label": "consequence"}, {"doc_id": 4493951, "edit_id": 5, "question": "Why were haloperidol and dexamethasone combined in the study, and what was the specific patient population being studied?", "category": "concept", "label": "cause"}, {"doc_id": 4493951, "edit_id": 6, "question": "What disease was being tracked or monitored in the study, and why is it important?", "category": "omission", "label": "concept"}, {"doc_id": 4517637, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4517637, "edit_id": 1, "question": "How did the researchers measure valine kinetics and FSRalb?", "category": "concept", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 2, "question": "What statistical test was used to compare the medians of the two groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 3, "question": "What was the age and weight of the participants in the study?", "category": "concept", "label": "extent"}, {"doc_id": 4517637, "edit_id": 4, "question": "Why were the researchers unable to draw conclusions on the effect of a HP diet on protein synthesis and balance?", "category": "omission", "label": "cause"}, {"doc_id": 4517637, "edit_id": 5, "question": "What is the possible mechanism by which the surplus protein in the HP group led to increased valine oxidation and ureagenesis?", "category": "concept", "label": "cause"}, {"doc_id": 4517637, "edit_id": 6, "question": "What is the trial registration number of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4555141, "edit_id": 0, "question": "How many infants were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4555141, "edit_id": 1, "question": "Was there a follow-up trial?", "category": "omission", "label": "verification"}, {"doc_id": 4555141, "edit_id": 2, "question": "What specific nutrients were included in the multiple micronutrient supplement?", "category": "concept", "label": "concept"}, {"doc_id": 4555141, "edit_id": 3, "question": "Did the study examine the effects of supplementation on cognitive development, social-emotional development, or both?", "category": "concept", "label": "disjunction"}, {"doc_id": 4555141, "edit_id": 4, "question": "What was the study design used in the original study?", "category": "omission", "label": "concept"}, {"doc_id": 4555141, "edit_id": 5, "question": "What were the results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4555141, "edit_id": 6, "question": "What specific test was used to measure intelligence in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4555141, "edit_id": 7, "question": "What specific test was used to measure social skills in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4555141, "edit_id": 8, "question": "What was the age range of the children in the follow-up trial?", "category": "omission", "label": "extent"}, {"doc_id": 4555141, "edit_id": 9, "question": "What were the results of the follow-up trial?", "category": "omission", "label": "consequence"}, {"doc_id": 4562579, "edit_id": 0, "question": "What are the effects of step-reduction on muscle health in older adults?", "category": "omission", "label": "concept"}, {"doc_id": 4562579, "edit_id": 1, "question": "What is the Partial Mayo Score and why is it important in this study?", "category": "omission", "label": "concept"}, {"doc_id": 4562579, "edit_id": 2, "question": "How does citrulline work in the body to improve muscle health?", "category": "concept", "label": "concept"}, {"doc_id": 4562579, "edit_id": 3, "question": "What was the age of the participants in the study and how long did the study last?", "category": "omission", "label": "extent"}, {"doc_id": 4562579, "edit_id": 4, "question": "What was the change in leg fat-free mass in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4562579, "edit_id": 5, "question": "How does resistance exercise affect protein creation in muscles?", "category": "concept", "label": "cause"}, {"doc_id": 4574984, "edit_id": 0, "question": "What measure of disease activity was used in the study for ulcerative colitis patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 1, "question": "What was the average length of hospital stay for patients in the study?", "category": "concept", "label": "extent"}, {"doc_id": 4574984, "edit_id": 2, "question": "What measure of quality of life was used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 3, "question": "What were the independent predictors of postoperative length of stay identified in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4574984, "edit_id": 4, "question": "What types of complications were tracked in the study?", "category": "concept", "label": "example"}, {"doc_id": 4574984, "edit_id": 5, "question": "What was the Timed Up and Go-test used for in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 6, "question": "What is the Clinicaltrials.gov identifier for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4577567, "edit_id": 0, "question": "What was the purpose of the stride frequency manipulation training?", "category": "omission", "label": "concept"}, {"doc_id": 4577567, "edit_id": 1, "question": "How many participants were in each group, and how were they assigned to the groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4577567, "edit_id": 2, "question": "What was the difference between the stride frequency manipulation and free stride frequency training?", "category": "concept", "label": "comparison"}, {"doc_id": 4577567, "edit_id": 3, "question": "What were the results of the study in terms of changes in stride length, contact time, stride frequency, and internal work?", "category": "omission", "label": "consequence"}, {"doc_id": 4577567, "edit_id": 4, "question": "What are the implications of the study's results for coaches and athletes, and what are the potential benefits of using slopes as RWM?", "category": "omission", "label": "consequence"}, {"doc_id": 4599047, "edit_id": 0, "question": "What were the specific symptoms that the Superion\u00ae was tested to treat?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 1, "question": "What were the specific components of the primary composite endpoint used to measure the success of the treatment?", "category": "concept", "label": "procedural"}, {"doc_id": 4599047, "edit_id": 2, "question": "When was the study conducted and how many investigational sites were involved?", "category": "omission", "label": "extent"}, {"doc_id": 4599047, "edit_id": 3, "question": "What was the specific population that the Superion\u00ae was tested for?", "category": "concept", "label": "concept"}, {"doc_id": 4599047, "edit_id": 4, "question": "What was the partial mayo score used to measure in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4599047, "edit_id": 5, "question": "What were the specific clinical outcomes measured in the study to determine the effectiveness of the Superion\u00ae device?", "category": "concept", "label": "consequence"}, {"doc_id": 4609664, "edit_id": 0, "question": "What was the purpose of this study?", "category": "omission", "label": "cause"}, {"doc_id": 4609664, "edit_id": 1, "question": "How many teeth were used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4609664, "edit_id": 2, "question": "What was the severity of the dentinal cracks caused by each treatment method?", "category": "concept", "label": "comparison"}, {"doc_id": 4609664, "edit_id": 3, "question": "What statistical methods were used to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 4, "question": "What was the level of significance set for the study?", "category": "concept", "label": "verification"}, {"doc_id": 4609664, "edit_id": 5, "question": "What were the results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4609664, "edit_id": 6, "question": "How did Reciproc compare to Mtwo and ProTaper Universal in terms of damage caused?", "category": "concept", "label": "comparison"}, {"doc_id": 4609664, "edit_id": 7, "question": "What was the conclusion of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4624894, "edit_id": 0, "question": "What is the current understanding of the optimal treatment for HCV genotype 6?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 1, "question": "What is the Partial Mayo Score, and how does it relate to UC disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 2, "question": "What is the specific threshold for low vitamin D levels in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4624894, "edit_id": 3, "question": "What type of survey was used to assess quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4624894, "edit_id": 4, "question": "What was the specific treatment regimen used in the study for HCV genotype 6 patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4624894, "edit_id": 5, "question": "How many patients were included in the study, and how were they randomized?", "category": "omission", "label": "procedural"}, {"doc_id": 4624894, "edit_id": 6, "question": "What was the primary outcome measure of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4624894, "edit_id": 7, "question": "What was the percentage of patients who developed anemia in the 48-week group?", "category": "concept", "label": "extent"}, {"doc_id": 4624894, "edit_id": 8, "question": "What was the limitation of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4687242, "edit_id": 0, "question": "What are some of the traditional uses of Ashwagandha?", "category": "omission", "label": "example"}, {"doc_id": 4687242, "edit_id": 1, "question": "What is cardiorespiratory endurance?", "category": "concept", "label": "concept"}, {"doc_id": 4687242, "edit_id": 2, "question": "What questionnaire was used to assess quality of life in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 3, "question": "What was the exact increase in mean VO2 max for the Ashwagandha group at 8 and 12 weeks, and how did the study compare the results to the placebo group?", "category": "concept", "label": "comparison"}, {"doc_id": 4687242, "edit_id": 4, "question": "What was the conclusion of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4704894, "edit_id": 0, "question": "How many participants were involved in the study, and what were their demographics?", "category": "omission", "label": "extent"}, {"doc_id": 4704894, "edit_id": 1, "question": "What specific content did the posts contain, and how did they relate to the participants' readiness to quit smoking?", "category": "omission", "label": "concept"}, {"doc_id": 4704894, "edit_id": 2, "question": "What specific content did the posts contain, and how did they relate to the participants' readiness to quit smoking?", "category": "omission", "label": "concept"}, {"doc_id": 4704894, "edit_id": 3, "question": "What assessment was used to determine the participants' readiness to quit smoking, and how did the groups differ based on their stage of change?", "category": "concept", "label": "procedural"}, {"doc_id": 4704894, "edit_id": 4, "question": "What specific content or prompts were used in each group, and how did they relate to the participants' stage of change?", "category": "concept", "label": "procedural"}, {"doc_id": 4704894, "edit_id": 5, "question": "What specific prompts were used to encourage participants to engage with the content?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 0, "question": "What was the objective of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4717319, "edit_id": 1, "question": "What was the method used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 2, "question": "What was the dosage of lurasidone used in the study?", "category": "concept", "label": "extent"}, {"doc_id": 4717319, "edit_id": 3, "question": "What was the criteria used to determine clinical stability in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4717319, "edit_id": 4, "question": "How many patients participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4717319, "edit_id": 5, "question": "What was the reduction in symptoms observed during the open-label phase?", "category": "omission", "label": "extent"}, {"doc_id": 4717319, "edit_id": 6, "question": "What were the results of the double-blind phase of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4717319, "edit_id": 7, "question": "What was the probability of relapse at the double-blind week 28 endpoint?", "category": "omission", "label": "extent"}, {"doc_id": 4717319, "edit_id": 8, "question": "Were there any changes in weight, lipid, glucose, and prolactin observed throughout the study?", "category": "omission", "label": "verification"}, {"doc_id": 4717613, "edit_id": 0, "question": "What was the study design used in this research?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 1, "question": "What was the specific threshold for low vitamin D levels in this study?", "category": "concept", "label": "concept"}, {"doc_id": 4717613, "edit_id": 2, "question": "What measure of disease activity was used in this study for ulcerative colitis patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 3, "question": "What were the specific nutrients included in the special diet that were thought to boost the immune system?", "category": "concept", "label": "concept"}, {"doc_id": 4717613, "edit_id": 4, "question": "What surgical methods were used in the study, and how did they differ between the experimental and control groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 5, "question": "What specific complications did the study find in the control group, and how did they differ from the nutrition group?", "category": "concept", "label": "consequence"}, {"doc_id": 4717613, "edit_id": 6, "question": "What was the average time to chest tube removal in the study, and how did it differ between the experimental and control groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4768925, "edit_id": 0, "question": "What is the effect of butylphthalide sodium chloride injection on patients with acute cerebral infarction?", "category": "omission", "label": "consequence"}, {"doc_id": 4768925, "edit_id": 1, "question": "How does butylphthalide sodium chloride injection affect the immune system?", "category": "concept", "label": "cause"}, {"doc_id": 4768925, "edit_id": 2, "question": "How were the levels of ACTH, COR, and NIHSS scores detected?", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 3, "question": "What were the specific levels of ACTH, COR, and NIHSS scores for both groups?", "category": "concept", "label": "extent"}, {"doc_id": 4768925, "edit_id": 4, "question": "What software was used for data analysis?", "category": "omission", "label": "procedural"}, {"doc_id": 4769147, "edit_id": 0, "question": "What are the benefits of breastfeeding for infants?", "category": "omission", "label": "consequence"}, {"doc_id": 4769147, "edit_id": 1, "question": "What is controlled limited formula usage?", "category": "concept", "label": "concept"}, {"doc_id": 4769147, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4769147, "edit_id": 3, "question": "What is the difference between exclusive and any breastfeeding?", "category": "concept", "label": "comparison"}, {"doc_id": 4769147, "edit_id": 4, "question": "What were the findings of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4769147, "edit_id": 5, "question": "What is the threshold for vitamin D levels in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4769147, "edit_id": 6, "question": "What is the trial registration number for the study?", "category": "omission", "label": "concept"}, {"doc_id": 4784207, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4784207, "edit_id": 1, "question": "What was the purpose of the separate written consent form?", "category": "concept", "label": "concept"}, {"doc_id": 4784207, "edit_id": 2, "question": "What methods were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4784207, "edit_id": 3, "question": "What was the composite adequacy of consent index and how was it generated?", "category": "concept", "label": "concept"}, {"doc_id": 4784207, "edit_id": 4, "question": "What were the conclusions of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 0, "question": "What are the potential complications of using a ureteral stent during a kidney transplant?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 1, "question": "What is stent crustation in the context of a kidney transplant?", "category": "concept", "label": "concept"}, {"doc_id": 4796524, "edit_id": 2, "question": "What is the Partial Mayo Score for UC disease activity, and why is it important in the context of a kidney transplant?", "category": "omission", "label": "concept"}, {"doc_id": 4796524, "edit_id": 3, "question": "What was the rate of urinary leakage in the study, and which group had a higher rate of leakage?", "category": "concept", "label": "comparison"}, {"doc_id": 4796524, "edit_id": 4, "question": "What were the rates of urinary tract infections (UTIs) reported in the study, and how did they compare between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4796524, "edit_id": 5, "question": "What was the rate of stent crustation in the study, and which group had a higher rate of crustation?", "category": "concept", "label": "comparison"}, {"doc_id": 4796524, "edit_id": 6, "question": "What was the conclusion of the study, and what does it suggest about the new technique?", "category": "omission", "label": "consequence"}, {"doc_id": 4808872, "edit_id": 0, "question": "What type of strength test was used to measure the athletes' strength?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 1, "question": "What type of training bouts were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 2, "question": "What is postactivation potentiation (PAP) time and why is it important?", "category": "concept", "label": "concept"}, {"doc_id": 4808872, "edit_id": 3, "question": "What is the Partial Mayo Score and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4808872, "edit_id": 4, "question": "What is explosive performance in the context of the study?", "category": "concept", "label": "concept"}, {"doc_id": 4808872, "edit_id": 5, "question": "What was the placebo used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 6, "question": "How long did the creatine supplementation last in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4808872, "edit_id": 7, "question": "What does 'significant earlier' mean in the context of the study?", "category": "concept", "label": "concept"}, {"doc_id": 4808872, "edit_id": 8, "question": "What specific measures were used to assess explosive performance in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 9, "question": "What is muscle fatigue and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4877819, "edit_id": 0, "question": "What are some of the potential benefits of A. paniculata, and how do they relate to its effects in animal models and clinical studies?", "category": "omission", "label": "example"}, {"doc_id": 4877819, "edit_id": 1, "question": "What is the Partial Mayo Score, and why is it important in measuring disease activity in multiple sclerosis patients?", "category": "omission", "label": "concept"}, {"doc_id": 4877819, "edit_id": 2, "question": "What was the design of the study, and what does 'placebo-controlled' mean in this context?", "category": "concept", "label": "procedural"}, {"doc_id": 4877819, "edit_id": 3, "question": "What are the Fatigue Severity Scores (FSS), and how do they relate to the study's measurement of fatigue levels?", "category": "concept", "label": "concept"}, {"doc_id": 4877819, "edit_id": 4, "question": "What were the inflammatory parameters and radiological findings that were investigated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4893758, "edit_id": 0, "question": "In what setting did the study take place?", "category": "omission", "label": "procedural"}, {"doc_id": 4893758, "edit_id": 1, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4893758, "edit_id": 2, "question": "What is PSA?", "category": "concept", "label": "concept"}, {"doc_id": 4893758, "edit_id": 3, "question": "What is fentanyl/midazolam?", "category": "concept", "label": "concept"}, {"doc_id": 4893758, "edit_id": 4, "question": "What were the specific characteristics that were compared between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4893758, "edit_id": 5, "question": "How many participants were in the study, and what was the gender breakdown?", "category": "omission", "label": "extent"}, {"doc_id": 4893758, "edit_id": 6, "question": "What kind of problems occurred during the study?", "category": "concept", "label": "consequence"}, {"doc_id": 4893758, "edit_id": 7, "question": "What were the specific results of the study in terms of procedural time, failure rate, and patient satisfaction?", "category": "omission", "label": "consequence"}, {"doc_id": 4914313, "edit_id": 0, "question": "What is the context of this study?", "category": "omission", "label": "concept"}, {"doc_id": 4914313, "edit_id": 1, "question": "What is the specific type of pancreatic cancer being studied?", "category": "concept", "label": "concept"}, {"doc_id": 4914313, "edit_id": 2, "question": "How were the patients divided into treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4914313, "edit_id": 3, "question": "What specific clinical outcomes were measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4914313, "edit_id": 4, "question": "What was the specific outcome associated with high miR-21 levels?", "category": "omission", "label": "consequence"}, {"doc_id": 4937273, "edit_id": 0, "question": "How does alirocumab work in the body?", "category": "omission", "label": "concept"}, {"doc_id": 4937273, "edit_id": 1, "question": "What measure of disease activity was used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4937273, "edit_id": 2, "question": "What is the dosing schedule of alirocumab and is it approved for use?", "category": "omission", "label": "concept"}, {"doc_id": 4937273, "edit_id": 3, "question": "What was the percentage of LDL-C reduction in each group and at what timepoint did it occur?", "category": "concept", "label": "extent"}, {"doc_id": 4937273, "edit_id": 4, "question": "What happened to free PCSK9 concentrations over time and how did it relate to alirocumab levels?", "category": "omission", "label": "comparison"}, {"doc_id": 4941128, "edit_id": 0, "question": "Was the deep brain stimulation applied to one or both sides of the brain?", "category": "omission", "label": "disjunction"}, {"doc_id": 4941128, "edit_id": 1, "question": "Where in the brain was the deep brain stimulation applied?", "category": "omission", "label": "concept"}, {"doc_id": 4941128, "edit_id": 2, "question": "What type of brain activity was used to guide the deep brain stimulation?", "category": "concept", "label": "concept"}, {"doc_id": 4941128, "edit_id": 3, "question": "What does 'ToS' stand for in the context of deep brain stimulation?", "category": "omission", "label": "concept"}, {"doc_id": 4941128, "edit_id": 4, "question": "What is the UPDRS and what does it measure?", "category": "concept", "label": "concept"}, {"doc_id": 4941128, "edit_id": 5, "question": "How was motor function assessed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 6, "question": "What is Levodopa and how does it work in the body?", "category": "concept", "label": "concept"}, {"doc_id": 4967511, "edit_id": 0, "question": "When did the study start recruiting participants?", "category": "omission", "label": "extent"}, {"doc_id": 4967511, "edit_id": 1, "question": "What were the eligibility criteria for participating classes in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 2, "question": "What specific outcomes were assessed in each category, and how were they assessed?", "category": "concept", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 3, "question": "What was the primary outcome of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4967511, "edit_id": 4, "question": "What statistical methods were used to analyze the data?", "category": "concept", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 5, "question": "What is the trial registration information for this study?", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 0, "question": "What were the two training approaches used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4972969, "edit_id": 1, "question": "How many health facilities participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 2, "question": "Did all health workers in both arms receive IMID training?", "category": "omission", "label": "verification"}, {"doc_id": 4972969, "edit_id": 3, "question": "How many outpatient visits were analyzed in the study?", "category": "concept", "label": "extent"}, {"doc_id": 4972969, "edit_id": 4, "question": "How many health workers provided treatment in the study?", "category": "concept", "label": "extent"}, {"doc_id": 4972969, "edit_id": 5, "question": "What was the result of the study regarding the effect of OSS on workload?", "category": "omission", "label": "consequence"}, {"doc_id": 4984916, "edit_id": 0, "question": "What is the current usage of TIVAS in the UK?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 1, "question": "How do TIVAS and Hickman catheters compare in terms of cost and complexity?", "category": "omission", "label": "comparison"}, {"doc_id": 4984916, "edit_id": 2, "question": "What were the specific complications that were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4984916, "edit_id": 3, "question": "What is meant by 'quality-adjusted life years' in the context of the study?", "category": "concept", "label": "concept"}, {"doc_id": 4984916, "edit_id": 4, "question": "Was an economic evaluation conducted as part of the study?", "category": "omission", "label": "verification"}, {"doc_id": 4984916, "edit_id": 5, "question": "What were the results of the economic evaluation conducted as part of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4984916, "edit_id": 6, "question": "What is the level of uncertainty associated with the study results?", "category": "omission", "label": "extent"}, {"doc_id": 4994121, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 4994121, "edit_id": 1, "question": "What type of heart disease did the patients in the study have?", "category": "concept", "label": "concept"}, {"doc_id": 4994121, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4994121, "edit_id": 3, "question": "What were the drugs used in the combination and what were their dosages?", "category": "concept", "label": "procedural"}, {"doc_id": 4994121, "edit_id": 4, "question": "What were the criteria used to determine when to administer volume loading?", "category": "omission", "label": "procedural"}, {"doc_id": 4994121, "edit_id": 5, "question": "What specific measurements and test results were recorded in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4994121, "edit_id": 6, "question": "How many patients died during the study and what was the cause of death?", "category": "omission", "label": "extent"}, {"doc_id": 5002324, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5002324, "edit_id": 1, "question": "How many people participated in the study and what were their inclusion criteria?", "category": "omission", "label": "extent"}, {"doc_id": 5002324, "edit_id": 2, "question": "What were the tests used to measure balance and stability?", "category": "concept", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 3, "question": "What were the results of the study in terms of balance improvement?", "category": "concept", "label": "consequence"}, {"doc_id": 5002324, "edit_id": 4, "question": "What is the trial registration number for this study?", "category": "omission", "label": "concept"}, {"doc_id": 5002324, "edit_id": 5, "question": "Is there any additional information available for this study?", "category": "omission", "label": "verification"}, {"doc_id": 5018291, "edit_id": 0, "question": "What was the aim of the study described in the text?", "category": "omission", "label": "cause"}, {"doc_id": 5018291, "edit_id": 1, "question": "What were the specific treatment procedures used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 2, "question": "What were the secondary objectives of the study described in the text?", "category": "omission", "label": "concept"}, {"doc_id": 5018291, "edit_id": 3, "question": "What were the specific pain scores and analgesic consumption used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 4, "question": "What was the time to first rescue analgesics administration in the study described in the text?", "category": "omission", "label": "extent"}, {"doc_id": 5018291, "edit_id": 5, "question": "What were the specific superior analgesic effects of infiltration of ketamine plus bupivacaine in the study?", "category": "concept", "label": "consequence"}, {"doc_id": 5019463, "edit_id": 0, "question": "What happens if patients with glaucoma miss their follow-up appointments?", "category": "omission", "label": "consequence"}, {"doc_id": 5019463, "edit_id": 1, "question": "What was the purpose of the study, and what was being compared between community- and office-based settings?", "category": "concept", "label": "cause"}, {"doc_id": 5019463, "edit_id": 2, "question": "How were patients assigned to different groups, and what were the differences in the follow-up care settings?", "category": "omission", "label": "procedural"}, {"doc_id": 5019463, "edit_id": 3, "question": "What were the exact numbers of follow-up visits for each group, and were the differences between the groups statistically significant?", "category": "concept", "label": "extent"}, {"doc_id": 5019463, "edit_id": 4, "question": "What were the adherence rates for each group, and were the differences between the groups statistically significant?", "category": "omission", "label": "extent"}, {"doc_id": 5019971, "edit_id": 0, "question": "What is the relationship between abacavir and cardiovascular disease in HIV-infected patients?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 1, "question": "How does maraviroc work in the body to improve cardiovascular health?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 2, "question": "What specific variables were measured during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5019971, "edit_id": 3, "question": "What was the magnitude of the improvement in blood flow and was it statistically significant?", "category": "concept", "label": "extent"}, {"doc_id": 5019971, "edit_id": 4, "question": "What is the relationship between \u0394FMD and \u0394D-dimer or \u0394CD95+ CD4+ T cells?", "category": "concept", "label": "concept"}, {"doc_id": 5043523, "edit_id": 0, "question": "What was the hypothesis being tested in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 1, "question": "What is the name of the gene variant that increases the risk of heart disease, and how does it relate to folate intake?", "category": "concept", "label": "concept"}, {"doc_id": 5043523, "edit_id": 2, "question": "What is the name of the study that was used to test the hypothesis?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 3, "question": "What information did participants receive about their genotype?", "category": "omission", "label": "procedural"}, {"doc_id": 5043523, "edit_id": 4, "question": "What were the results of the study in terms of changes in folate intakes?", "category": "omission", "label": "consequence"}, {"doc_id": 5043523, "edit_id": 5, "question": "Were there any changes in reported intake of food groups high in folate?", "category": "omission", "label": "verification"}, {"doc_id": 5043523, "edit_id": 6, "question": "What method was used to assess changes in folate intake between the groups?", "category": "concept", "label": "procedural"}, {"doc_id": 5043523, "edit_id": 7, "question": "What is the trial registration number for this study?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 8, "question": "Is there any supplementary material available for this study?", "category": "omission", "label": "verification"}, {"doc_id": 5054596, "edit_id": 0, "question": "What specific tasks did the participants practice in the training group?", "category": "omission", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 1, "question": "How does the harness and cable control the prosthetic device, and what type of feedback does the user receive?", "category": "concept", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 2, "question": "What was the SHAP test, and how did the groups perform on it after a period of non-use?", "category": "omission", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 3, "question": "What specific improvements were made, and how did the type of training affect the improvements?", "category": "concept", "label": "comparison"}, {"doc_id": 5054596, "edit_id": 4, "question": "How did the participants' grip force control improve over training?", "category": "omission", "label": "extent"}, {"doc_id": 5054596, "edit_id": 5, "question": "What specific action-perception couplings were trained, and how did they transfer to functional tasks?", "category": "concept", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 6, "question": "Is there any supplementary material available for this study, and if so, what does it contain?", "category": "omission", "label": "verification"}, {"doc_id": 5117579, "edit_id": 0, "question": "What is the mechanism of action of dexmedetomidine?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 1, "question": "What measure of disease activity was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5117579, "edit_id": 2, "question": "What are some potential complications of spinal anesthesia?", "category": "omission", "label": "example"}, {"doc_id": 5117579, "edit_id": 3, "question": "Why is it important to decrease anxiety in patients before a procedure?", "category": "concept", "label": "cause"}, {"doc_id": 5117579, "edit_id": 4, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 5, "question": "What was the percentage of patients who experienced hypotension in each group?", "category": "concept", "label": "extent"}, {"doc_id": 5117579, "edit_id": 6, "question": "Was there a difference in the need for treatment of hypotension between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5117579, "edit_id": 7, "question": "What were the specific measures of anxiety and comfort used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 8, "question": "What is the clinical trial registration number for this study?", "category": "omission", "label": "concept"}, {"doc_id": 5122106, "edit_id": 0, "question": "What was the study design used in this research?", "category": "omission", "label": "concept"}, {"doc_id": 5122106, "edit_id": 1, "question": "Was the weight loss statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5122106, "edit_id": 2, "question": "What was the average reduction in waist size in the participants?", "category": "concept", "label": "extent"}, {"doc_id": 5122106, "edit_id": 3, "question": "What was the average reduction in abdominal fat thickness in the participants?", "category": "concept", "label": "extent"}, {"doc_id": 5122106, "edit_id": 4, "question": "Where was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5122106, "edit_id": 5, "question": "How were the participants divided into the case and control groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 6, "question": "What statistical tests were used to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 5122238, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5122238, "edit_id": 1, "question": "What are the complications of spinal anesthesia?", "category": "concept", "label": "example"}, {"doc_id": 5122238, "edit_id": 2, "question": "What were the dosages of hydrocortisone used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5122238, "edit_id": 3, "question": "What statistical test was used to compare the incidence of shivering between the three groups?", "category": "concept", "label": "procedural"}, {"doc_id": 5122238, "edit_id": 4, "question": "What was the conclusion of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5125190, "edit_id": 0, "question": "What is the name of the drug used for anesthesia in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5125190, "edit_id": 1, "question": "What was the purpose of the study described in the text?", "category": "omission", "label": "cause"}, {"doc_id": 5125190, "edit_id": 2, "question": "What was the incidence of pain in each group?", "category": "concept", "label": "extent"}, {"doc_id": 5125190, "edit_id": 3, "question": "How many patients were in each group, and how were they divided into groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 4, "question": "What is the partial mayo score, and what does UC stand for?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 0, "question": "What is the relationship between Tartary buckwheat and type 2 diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 1, "question": "What is UACR and how does it relate to kidney disease?", "category": "concept", "label": "concept"}, {"doc_id": 5125721, "edit_id": 2, "question": "What is urea nitrogen and how does it relate to kidney disease?", "category": "concept", "label": "concept"}, {"doc_id": 5125721, "edit_id": 3, "question": "What is the Partial Mayo Score and how does it relate to ulcerative colitis disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 4, "question": "What is diabetic kidney disease and how does it relate to diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 5, "question": "How does eating Tartary buckwheat daily help improve kidney health in diabetes patients?", "category": "concept", "label": "cause"}, {"doc_id": 5125721, "edit_id": 6, "question": "What were the specific outcomes of the study and how did they compare between the TB intervention group and the diet control group?", "category": "omission", "label": "comparison"}, {"doc_id": 5125721, "edit_id": 7, "question": "Were there any subgroup analyses conducted in the study and what were their results?", "category": "omission", "label": "verification"}, {"doc_id": 5125808, "edit_id": 0, "question": "What is the Partial Mayo Score and how does it relate to the study?", "category": "omission", "label": "concept"}, {"doc_id": 5125808, "edit_id": 1, "question": "What was the specific threshold of vitamin D levels used in the study to determine eligibility for participation?", "category": "concept", "label": "concept"}, {"doc_id": 5125808, "edit_id": 2, "question": "What was the name of the survey used to measure quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5125808, "edit_id": 3, "question": "What was the statistical significance of the results in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5125808, "edit_id": 4, "question": "What were the results of vital signs and physical examination findings in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5125808, "edit_id": 5, "question": "What were the adverse events observed in the study?", "category": "concept", "label": "consequence"}, {"doc_id": 5125808, "edit_id": 6, "question": "How was safety assessed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5129820, "edit_id": 0, "question": "What is the benefit of olaparib for patients with a BRCA1/2 mutation?", "category": "omission", "label": "consequence"}, {"doc_id": 5129820, "edit_id": 1, "question": "What surveys were used to evaluate quality of life and disease-related symptoms?", "category": "concept", "label": "procedural"}, {"doc_id": 5129820, "edit_id": 2, "question": "How many patients were in the study, and how many were in each arm?", "category": "omission", "label": "extent"}, {"doc_id": 5129820, "edit_id": 3, "question": "What was the compliance rate for HRQoL assessment, and over what time frame was it high?", "category": "concept", "label": "extent"}, {"doc_id": 5129820, "edit_id": 4, "question": "What were the results of the study regarding the time to worsening or improvement rates of TOI, FOSI and FACT-O scores?", "category": "omission", "label": "consequence"}, {"doc_id": 5223669, "edit_id": 0, "question": "What are the traditional analytic methods used for statistical analysis in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5223669, "edit_id": 1, "question": "What is constrained longitudinal data analysis (cLDA) and why is it used in this study?", "category": "concept", "label": "concept"}, {"doc_id": 5223669, "edit_id": 2, "question": "What was the result of the analysis with complete data?", "category": "omission", "label": "consequence"}, {"doc_id": 5223669, "edit_id": 3, "question": "What was the result of the analysis with all available data?", "category": "omission", "label": "consequence"}, {"doc_id": 5223669, "edit_id": 4, "question": "What are the assumptions made about missing data in this study and how do they affect the results?", "category": "concept", "label": "concept"}, {"doc_id": 5244020, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5244020, "edit_id": 1, "question": "How many participants were in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5244020, "edit_id": 2, "question": "What specific urinary symptoms were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5244020, "edit_id": 3, "question": "What specific outcomes were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5244020, "edit_id": 4, "question": "What type of surgery did the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5244020, "edit_id": 5, "question": "What were the two key differences found in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5301061, "edit_id": 0, "question": "What are the effects of lacking spiritual health on patients with hypertension?", "category": "omission", "label": "consequence"}, {"doc_id": 5301061, "edit_id": 1, "question": "What kind of religious program was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5301061, "edit_id": 2, "question": "How many participants were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5301061, "edit_id": 3, "question": "What was the name of the questionnaire used to measure spiritual wellbeing?", "category": "concept", "label": "procedural"}, {"doc_id": 5301061, "edit_id": 4, "question": "What statistical tests were used to analyze the data collected from the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 0, "question": "What was the concern of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5313491, "edit_id": 1, "question": "What was the specific strategy used in the study to restrict fluids?", "category": "concept", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 2, "question": "What were the primary and secondary outcomes measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5313491, "edit_id": 3, "question": "What were the specific restrictions on fluid maintenance and the conditions under which colloid boluses were allowed?", "category": "concept", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 4, "question": "What were the specific complications that occurred in the study and how did they differ between the two groups?", "category": "omission", "label": "consequence"}, {"doc_id": 5313491, "edit_id": 5, "question": "What was the specific association between GDFR and the reduction in ICU length of stay, costs, and postoperative morbidity?", "category": "concept", "label": "consequence"}, {"doc_id": 5350209, "edit_id": 0, "question": "What happens if you drink alcohol quickly?", "category": "omission", "label": "consequence"}, {"doc_id": 5350209, "edit_id": 1, "question": "What kind of health warnings were used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5350209, "edit_id": 2, "question": "What was the vitamin D level of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5350209, "edit_id": 3, "question": "What is the Partial Mayo Score?", "category": "omission", "label": "concept"}, {"doc_id": 5350209, "edit_id": 4, "question": "What was the purpose of the study?", "category": "concept", "label": "cause"}, {"doc_id": 5350209, "edit_id": 5, "question": "How many participants were in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5350209, "edit_id": 6, "question": "What were the results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5350209, "edit_id": 7, "question": "What is product acceptability?", "category": "concept", "label": "concept"}, {"doc_id": 5350209, "edit_id": 8, "question": "What is the significance of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5379203, "edit_id": 0, "question": "What was the study comparing?", "category": "omission", "label": "comparison"}, {"doc_id": 5379203, "edit_id": 1, "question": "What was the study design?", "category": "omission", "label": "concept"}, {"doc_id": 5379203, "edit_id": 2, "question": "What was the AHI threshold for receiving CPAP treatment?", "category": "omission", "label": "concept"}, {"doc_id": 5379203, "edit_id": 3, "question": "What were the outcome measures of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5379203, "edit_id": 4, "question": "What was the cost difference between the home-based and hospital-based approaches?", "category": "concept", "label": "comparison"}, {"doc_id": 5379203, "edit_id": 5, "question": "What was the waiting time for patients receiving CPAP treatment?", "category": "omission", "label": "extent"}, {"doc_id": 5416724, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5416724, "edit_id": 1, "question": "Where was the study conducted?", "category": "concept", "label": "concept"}, {"doc_id": 5416724, "edit_id": 2, "question": "What were the inclusion criteria for the study?", "category": "omission", "label": "concept"}, {"doc_id": 5416724, "edit_id": 3, "question": "What specific metrics were used to measure the ease of intubation?", "category": "concept", "label": "procedural"}, {"doc_id": 5416724, "edit_id": 4, "question": "What were the specific results of the study in terms of the reduction in IDS score and comparison between the AirtraqTM and Macintosh laryngoscopes?", "category": "omission", "label": "consequence"}, {"doc_id": 5416724, "edit_id": 5, "question": "What specific haemodynamic variables were measured during the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5416724, "edit_id": 6, "question": "What was the study design?", "category": "omission", "label": "procedural"}, {"doc_id": 5433398, "edit_id": 0, "question": "What kind of patients were included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5433398, "edit_id": 1, "question": "What was the goal of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5433398, "edit_id": 2, "question": "What did the integrated approach entail?", "category": "concept", "label": "procedural"}, {"doc_id": 5433398, "edit_id": 3, "question": "What were the results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5433398, "edit_id": 4, "question": "What is the MSIS-29 scale and why was it used to measure quality of life?", "category": "concept", "label": "concept"}, {"doc_id": 5440036, "edit_id": 0, "question": "What was the study design used in this research?", "category": "omission", "label": "procedural"}, {"doc_id": 5440036, "edit_id": 1, "question": "What kind of surgery was conducted in this study and how severe was the nausea and vomiting?", "category": "concept", "label": "procedural"}, {"doc_id": 5440036, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5440036, "edit_id": 3, "question": "What was the exact dose of palonosetron used in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5440036, "edit_id": 4, "question": "Did all patients complete the trial?", "category": "omission", "label": "verification"}, {"doc_id": 5440036, "edit_id": 5, "question": "What was the exact dose of palonosetron used in the study and how did combining low-dose palonosetron with droperidol affect the prevention of post-surgery sickness?", "category": "concept", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 0, "question": "What are the challenges faced by patients in low-income settings when it comes to CBT for depression?", "category": "omission", "label": "example"}, {"doc_id": 5440738, "edit_id": 1, "question": "How does automated messaging encourage sustained engagement with psychotherapy in depression treatment?", "category": "concept", "label": "cause"}, {"doc_id": 5440738, "edit_id": 2, "question": "What was the control condition in the study, and what was the sample size of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 3, "question": "What was the result of the statistical analysis in the study, and how did the text messaging adjunct affect depressive symptom severity?", "category": "concept", "label": "consequence"}, {"doc_id": 5440738, "edit_id": 4, "question": "What is the conclusion of the study, and what are the implications of the results?", "category": "omission", "label": "consequence"}, {"doc_id": 5442667, "edit_id": 0, "question": "Why are older adults more likely to be prescribed inappropriate medications?", "category": "omission", "label": "cause"}, {"doc_id": 5442667, "edit_id": 1, "question": "What are the potential health risks associated with anticholinergic drugs?", "category": "omission", "label": "consequence"}, {"doc_id": 5442667, "edit_id": 2, "question": "What is the Partial Mayo Score and why is it important in assessing disease activity?", "category": "concept", "label": "concept"}, {"doc_id": 5442667, "edit_id": 3, "question": "What are MTM interventions and why are they important in managing medications for older adults?", "category": "concept", "label": "concept"}, {"doc_id": 5442667, "edit_id": 4, "question": "Where was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 5, "question": "How many participants were in the study and what were their medication habits?", "category": "omission", "label": "extent"}, {"doc_id": 5442667, "edit_id": 6, "question": "What were the mean MAI and ADS scores, and how many participants used multiple anticholinergic medications?", "category": "omission", "label": "consequence"}, {"doc_id": 5448649, "edit_id": 0, "question": "What does aBTC stand for?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 1, "question": "What does PPV stand for?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 2, "question": "What are HLA-matched peptides?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 3, "question": "What is progression-free survival?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 4, "question": "What is overall survival?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 5, "question": "What is low dose cyclophosphamide and what is it used for?", "category": "concept", "label": "concept"}, {"doc_id": 5448649, "edit_id": 6, "question": "What is IL-6 protein and what is its role in the immune system?", "category": "concept", "label": "concept"}, {"doc_id": 5448649, "edit_id": 7, "question": "What does the combination of CPA and PPV do and why is it used?", "category": "concept", "label": "concept"}, {"doc_id": 5491994, "edit_id": 0, "question": "What medical field does the study focus on?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 1, "question": "What is the compliance rate of patients with elective surgeries?", "category": "omission", "label": "extent"}, {"doc_id": 5491994, "edit_id": 2, "question": "What imaging technique was used to create the 3D model?", "category": "concept", "label": "procedural"}, {"doc_id": 5491994, "edit_id": 3, "question": "What aspect of anatomy did patients rate in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5491994, "edit_id": 4, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 5, "question": "What was the study design used in the research?", "category": "omission", "label": "procedural"}, {"doc_id": 5491994, "edit_id": 6, "question": "What was the sample size of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5491994, "edit_id": 7, "question": "Were the results of the study statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5498715, "edit_id": 0, "question": "What are the benefits of physical activity in preventing chronic diseases?", "category": "omission", "label": "consequence"}, {"doc_id": 5498715, "edit_id": 1, "question": "What is Self-determination theory (SDT) and how does it relate to motivational interviewing (MI)?", "category": "omission", "label": "concept"}, {"doc_id": 5498715, "edit_id": 2, "question": "What specific questionnaires and variables were included in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 3, "question": "How were the questionnaires validated?", "category": "omission", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 4, "question": "How was the reliability and internal consistency of the questionnaires and measures tested?", "category": "omission", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 5, "question": "What was the content of the motivational interviewing sessions and the standard education session?", "category": "concept", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 6, "question": "What did the control group receive in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 0, "question": "What was the name of the trial that was conducted in Mexico and Nicaragua?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 1, "question": "In which state and region of Mexico was the trial conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 2, "question": "What were the specific activities that were conducted as part of the trial to educate and mobilise communities?", "category": "concept", "label": "procedural"}, {"doc_id": 5506592, "edit_id": 3, "question": "What was the percentage of households in the intervention and control groups that spent more than the mean expenditure on anti-mosquito products?", "category": "concept", "label": "extent"}, {"doc_id": 5506592, "edit_id": 4, "question": "What was the trial registration number for the Camino Verde trial?", "category": "omission", "label": "concept"}, {"doc_id": 5506697, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5506697, "edit_id": 1, "question": "How was the study conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 2, "question": "What were the specific inclusion criteria for patients in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5506697, "edit_id": 3, "question": "What questionnaire was used to measure quality of life in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 4, "question": "What were the results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5506697, "edit_id": 5, "question": "What were the conclusions of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5513842, "edit_id": 0, "question": "What is the potential outcome of having a cholecystectomy?", "category": "omission", "label": "consequence"}, {"doc_id": 5513842, "edit_id": 1, "question": "How does PVB help with pain management after cholecystectomy?", "category": "concept", "label": "cause"}, {"doc_id": 5513842, "edit_id": 2, "question": "What is the Partial Mayo Score?", "category": "omission", "label": "concept"}, {"doc_id": 5513842, "edit_id": 3, "question": "What were the pain scores reported by the PVB and control groups 24 hours after surgery?", "category": "concept", "label": "extent"}, {"doc_id": 5513842, "edit_id": 4, "question": "What were the opioid consumption levels in the PVB and control groups?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 5, "question": "What was the first analgesic requirement time in the PVB group?", "category": "omission", "label": "extent"}, {"doc_id": 5514258, "edit_id": 0, "question": "What is the source of the data used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 1, "question": "How were the patients risk-stratified?", "category": "omission", "label": "procedural"}, {"doc_id": 5514258, "edit_id": 2, "question": "What are the criteria for high-risk patients?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 3, "question": "What are the criteria for intermediate-risk patients?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 4, "question": "What was the specific survival benefit found in the study for high-risk patients who received radiation therapy?", "category": "concept", "label": "extent"}, {"doc_id": 5514258, "edit_id": 5, "question": "What was the specific survival outcome for intermediate-risk patients in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5514258, "edit_id": 6, "question": "What was the specific survival outcome for low-risk patients in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5514258, "edit_id": 7, "question": "What was the limitation of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5518918, "edit_id": 0, "question": "What are the challenges associated with cardiac rehabilitation?", "category": "omission", "label": "concept"}, {"doc_id": 5518918, "edit_id": 1, "question": "What type of training did the patients receive at home?", "category": "concept", "label": "concept"}, {"doc_id": 5518918, "edit_id": 2, "question": "What is the Partial Mayo Score and how does it relate to the study?", "category": "omission", "label": "concept"}, {"doc_id": 5518918, "edit_id": 3, "question": "What aspect of physical fitness was measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5518918, "edit_id": 4, "question": "Was the home-based training more cost-effective than the center-based training?", "category": "omission", "label": "verification"}, {"doc_id": 5518918, "edit_id": 5, "question": "Was the home-based training more cost-effective from a societal perspective?", "category": "omission", "label": "verification"}, {"doc_id": 5529957, "edit_id": 0, "question": "What was the condition of the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5529957, "edit_id": 1, "question": "Were all the patients in the study newly diagnosed with CTEPH?", "category": "omission", "label": "verification"}, {"doc_id": 5529957, "edit_id": 2, "question": "What is PVR and how does it relate to lung function?", "category": "concept", "label": "concept"}, {"doc_id": 5529957, "edit_id": 3, "question": "What is cardiac index and how does it relate to heart function?", "category": "concept", "label": "concept"}, {"doc_id": 5529957, "edit_id": 4, "question": "What was the age and gender distribution of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5529957, "edit_id": 5, "question": "What was the trial registration number for the study?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 0, "question": "What was the aim of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5545112, "edit_id": 1, "question": "What methods were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 2, "question": "What is the Partial Mayo Score and how does it measure disease severity?", "category": "concept", "label": "concept"}, {"doc_id": 5545112, "edit_id": 3, "question": "What is the SIBDQ and how does it measure quality of life?", "category": "concept", "label": "concept"}, {"doc_id": 5545112, "edit_id": 4, "question": "How was the data analyzed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 5, "question": "How many patients were in each group?", "category": "omission", "label": "extent"}, {"doc_id": 5555437, "edit_id": 0, "question": "What was the name of the trial that was conducted to determine the best treatment plan for limited-stage small-cell lung cancer?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 1, "question": "What was the performance status of the patients in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 2, "question": "How many cycles of chemotherapy were planned for the patients in the trial?", "category": "omission", "label": "extent"}, {"doc_id": 5555437, "edit_id": 3, "question": "How were the patients in the trial assigned to receive either twice-daily or once-daily radiotherapy?", "category": "omission", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 4, "question": "What type of lung cancer was studied in the trial?", "category": "concept", "label": "concept"}, {"doc_id": 5555437, "edit_id": 5, "question": "What was the treatment plan used in the trial?", "category": "concept", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 6, "question": "What were the severe side effects experienced by the patients in the trial?", "category": "concept", "label": "consequence"}, {"doc_id": 5571493, "edit_id": 0, "question": "What were the mean glycemic levels during the 4-hour infusion in the quinine and non-quinine groups, and were the differences between the groups statistically significant?", "category": "omission", "label": "comparison"}, {"doc_id": 5571493, "edit_id": 1, "question": "What specific type of ECG test was performed, and which parameters were measured?", "category": "concept", "label": "procedural"}, {"doc_id": 5571493, "edit_id": 2, "question": "Was the order of the experiments randomized?", "category": "omission", "label": "verification"}, {"doc_id": 5571493, "edit_id": 3, "question": "What specific glycemic effects of quinine were measured in the study, and what was the population studied?", "category": "concept", "label": "procedural"}, {"doc_id": 5571493, "edit_id": 4, "question": "What is the partial mayo score, and why is it important in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 0, "question": "What is the background of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 1, "question": "What are the specific health risks associated with inhaling particulate matter?", "category": "concept", "label": "consequence"}, {"doc_id": 5588713, "edit_id": 2, "question": "How do nanoparticles cause inflammation and blood clotting?", "category": "concept", "label": "cause"}, {"doc_id": 5588713, "edit_id": 3, "question": "What were the study's findings on the effect of carbon nanoparticles on circulating neutrophils?", "category": "omission", "label": "consequence"}, {"doc_id": 5588713, "edit_id": 4, "question": "Is the study registered?", "category": "omission", "label": "verification"}, {"doc_id": 5588713, "edit_id": 5, "question": "Is there any supplementary material available for this study?", "category": "omission", "label": "verification"}, {"doc_id": 5626376, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5626376, "edit_id": 1, "question": "What were the patient inclusion criteria and methods used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 2, "question": "What is HA1 and what is its composition?", "category": "concept", "label": "concept"}, {"doc_id": 5626376, "edit_id": 3, "question": "What is HA2 and what is its composition?", "category": "concept", "label": "concept"}, {"doc_id": 5626376, "edit_id": 4, "question": "What is HA3 and what is its composition?", "category": "concept", "label": "concept"}, {"doc_id": 5626376, "edit_id": 5, "question": "What is PRP and how is it prepared?", "category": "concept", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 6, "question": "What were the results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5626376, "edit_id": 7, "question": "What was the conclusion of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 5682159, "edit_id": 0, "question": "Why are patient-reported outcomes important in aesthetic procedures?", "category": "omission", "label": "cause"}, {"doc_id": 5682159, "edit_id": 1, "question": "What was the study design used in this research?", "category": "omission", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 2, "question": "What type of treatment was used in the study and what was the dosage?", "category": "concept", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 3, "question": "What injection technique and volume were used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 4, "question": "Were there any restrictions on anesthetics, overcorrection, and touch-ups during the study?", "category": "omission", "label": "verification"}, {"doc_id": 5682159, "edit_id": 5, "question": "How long was the follow-up period in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5682159, "edit_id": 6, "question": "What was the level of satisfaction with the treatment among the participants?", "category": "concept", "label": "consequence"}, {"doc_id": 5682159, "edit_id": 7, "question": "What percentage of subjects were satisfied with both treatments throughout the study?", "category": "omission", "label": "extent"}, {"doc_id": 5682159, "edit_id": 8, "question": "What was the percentage of subjects who were more satisfied with the CPM-26-treated side of the face?", "category": "concept", "label": "extent"}, {"doc_id": 5702778, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5702778, "edit_id": 1, "question": "How many teeth were used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5702778, "edit_id": 2, "question": "How long did the experiment last?", "category": "omission", "label": "extent"}, {"doc_id": 5702778, "edit_id": 3, "question": "What type of test was used to measure the hardness of the enamel?", "category": "concept", "label": "procedural"}, {"doc_id": 5702778, "edit_id": 4, "question": "What type of microscope was used to examine the enamel?", "category": "concept", "label": "procedural"}, {"doc_id": 5702778, "edit_id": 5, "question": "How did the researchers determine that the microhardness changes were significant?", "category": "omission", "label": "procedural"}, {"doc_id": 5702778, "edit_id": 6, "question": "What were the results of the statistical analysis?", "category": "omission", "label": "consequence"}, {"doc_id": 5702778, "edit_id": 7, "question": "What did the SEM analysis show?", "category": "omission", "label": "consequence"}, {"doc_id": 5702778, "edit_id": 8, "question": "What happened to the adhesive material in the groups exposed to carbonated water?", "category": "omission", "label": "consequence"}, {"doc_id": 5730627, "edit_id": 0, "question": "What was the study design and population of the research?", "category": "omission", "label": "procedural"}, {"doc_id": 5771057, "edit_id": 0, "question": "What was the main goal of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 1, "question": "What was the age range of the participants in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5771057, "edit_id": 2, "question": "Which subtests of the WCJ-III assessment were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5771057, "edit_id": 3, "question": "What specific measures of performance were affected by task complexity, and how did the researchers determine this?", "category": "concept", "label": "procedural"}, {"doc_id": 5771057, "edit_id": 4, "question": "What did the linear regression analysis reveal about the relationship between the WCJ-III subtests and performance measures?", "category": "omission", "label": "consequence"}, {"doc_id": 5771057, "edit_id": 5, "question": "What is the purpose of the study, and which test was used to assess thinking skills?", "category": "concept", "label": "concept"}, {"doc_id": 5805261, "edit_id": 0, "question": "What measure was used to track the disease activity of patients with ulcerative colitis?", "category": "omission", "label": "procedural"}, {"doc_id": 5805261, "edit_id": 1, "question": "What was the specific threshold of vitamin D levels that was used to determine eligibility for the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5805261, "edit_id": 2, "question": "What technical parameters were evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5805261, "edit_id": 3, "question": "What type of RFA methods were used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5805261, "edit_id": 4, "question": "What survival rates were compared between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5805261, "edit_id": 5, "question": "What were the exact survival rates and the difference in ablation time between the two methods?", "category": "concept", "label": "comparison"}, {"doc_id": 5808396, "edit_id": 0, "question": "What type of study was conducted and where was it conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 1, "question": "What specific mental health problems were studied?", "category": "concept", "label": "concept"}, {"doc_id": 5808396, "edit_id": 2, "question": "What statistical methods were used to analyze the data and what were the specific outcomes measured?", "category": "omission", "label": "procedural"}, {"doc_id": 5808396, "edit_id": 3, "question": "What is felt stigma and how was it measured?", "category": "concept", "label": "concept"}, {"doc_id": 5808396, "edit_id": 4, "question": "What is enacted stigma and how did it relate to the study?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 5, "question": "What specific mental health issues were studied and how were they measured?", "category": "concept", "label": "concept"}, {"doc_id": 5808396, "edit_id": 6, "question": "What is the clinical trial registration number for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 0, "question": "What was the purpose of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5809707, "edit_id": 1, "question": "How did the researchers conduct the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 2, "question": "What was the exact dose of ketamine or fentanyl used in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5809707, "edit_id": 3, "question": "How was disease activity measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 4, "question": "How long did it take for patients to recover from anesthesia?", "category": "omission", "label": "extent"}, {"doc_id": 5809707, "edit_id": 5, "question": "What were the adverse effects of the sedation?", "category": "omission", "label": "consequence"}, {"doc_id": 5809707, "edit_id": 6, "question": "How much propofol did each group need?", "category": "concept", "label": "extent"}, {"doc_id": 5809707, "edit_id": 7, "question": "How were patient hemodynamics and oxygenation affected by the sedation?", "category": "concept", "label": "consequence"}, {"doc_id": 5827507, "edit_id": 0, "question": "What is the name of the condition that causes sharp and acute pain in patients?", "category": "omission", "label": "concept"}, {"doc_id": 5827507, "edit_id": 1, "question": "What have been the alternative treatment strategies for dentinal hypersensitivity?", "category": "concept", "label": "example"}, {"doc_id": 5827507, "edit_id": 2, "question": "What were the specifics of the treatment groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 3, "question": "What were the specific tests used to measure tooth sensitivity in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 4, "question": "What statistical analysis was used to compare the mean VAS scores between the treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 5, "question": "What were the specific results of the study in terms of pain relief reported by patients in Group 3?", "category": "omission", "label": "consequence"}, {"doc_id": 5827507, "edit_id": 6, "question": "What was the specific treatment recommendation made by the study authors?", "category": "concept", "label": "consequence"}, {"doc_id": 5852865, "edit_id": 0, "question": "What specific carotenoids are believed to protect the retina from age-related macular degeneration?", "category": "omission", "label": "concept"}, {"doc_id": 5852865, "edit_id": 1, "question": "Are supplements containing the carotenoids mentioned in the study available?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 2, "question": "What was the difference between the two supplements given in the study, and what was the dosage used?", "category": "concept", "label": "comparison"}, {"doc_id": 5852865, "edit_id": 3, "question": "What was the difference in response between the two groups, and what was the measure used to assess the response?", "category": "concept", "label": "comparison"}, {"doc_id": 5852865, "edit_id": 4, "question": "Was the difference between the two groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 5, "question": "Was there a trend towards smaller increases in macular pigment for subjects with high baseline values?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 6, "question": "Was the trend towards smaller increases in macular pigment for subjects with high baseline values significant for subjects in the diacetate group?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 7, "question": "Did gender have an effect on the response to the supplements?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 8, "question": "Did the use of statin drugs by older subjects affect their response to the supplements?", "category": "omission", "label": "verification"}, {"doc_id": 5861369, "edit_id": 0, "question": "What is adrenal hyperactivity?", "category": "omission", "label": "concept"}, {"doc_id": 5861369, "edit_id": 1, "question": "What is insulin resistance?", "category": "omission", "label": "concept"}, {"doc_id": 5861369, "edit_id": 2, "question": "What aspects of mental health were studied in the trial?", "category": "concept", "label": "concept"}, {"doc_id": 5861369, "edit_id": 3, "question": "What is the Partial Mayo Score for UC disease activity?", "category": "omission", "label": "concept"}, {"doc_id": 5861369, "edit_id": 4, "question": "What is the 3-h oral glucose tolerance test (OGTT)?", "category": "concept", "label": "concept"}, {"doc_id": 5861369, "edit_id": 5, "question": "What is body mass index (BMI)?", "category": "omission", "label": "concept"}, {"doc_id": 5861369, "edit_id": 6, "question": "What is waist circumference?", "category": "omission", "label": "concept"}, {"doc_id": 5861369, "edit_id": 7, "question": "What is the ACTH test?", "category": "concept", "label": "concept"}, {"doc_id": 5861369, "edit_id": 8, "question": "What is quality of life (HRQoL)?", "category": "omission", "label": "concept"}, {"doc_id": 5863413, "edit_id": 0, "question": "What is the cause of lichen planus?", "category": "omission", "label": "cause"}, {"doc_id": 5863413, "edit_id": 1, "question": "What are the adverse effects of corticosteroids in the treatment of oral lichen planus?", "category": "omission", "label": "consequence"}, {"doc_id": 5863413, "edit_id": 2, "question": "What is propolis and how is it made?", "category": "concept", "label": "concept"}, {"doc_id": 5863413, "edit_id": 3, "question": "Was the reduction in pain and erythema scores statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5863413, "edit_id": 4, "question": "What statistical tests were used to analyze the results?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 5, "question": "How did propolis compare to triamcinolone acetonide 0.1% in the management of oral lichen planus?", "category": "concept", "label": "comparison"}, {"doc_id": 5866486, "edit_id": 0, "question": "What was the goal of the study?", "category": "omission", "label": "cause"}, {"doc_id": 5866486, "edit_id": 1, "question": "What did the vestibular rehabilitation program consist of?", "category": "concept", "label": "procedural"}, {"doc_id": 5866486, "edit_id": 2, "question": "How was the vestibular rehabilitation program developed and validated?", "category": "omission", "label": "procedural"}, {"doc_id": 5866486, "edit_id": 3, "question": "What is the Dizziness Handicap Inventory and what does it measure?", "category": "concept", "label": "concept"}, {"doc_id": 5866486, "edit_id": 4, "question": "Were the physical conditions and DHI scores of patients in both groups similar at the beginning of the study?", "category": "omission", "label": "verification"}, {"doc_id": 5866486, "edit_id": 5, "question": "How was the effectiveness of the interventions measured?", "category": "concept", "label": "procedural"}, {"doc_id": 5866486, "edit_id": 6, "question": "How long did the study last, and what were the results?", "category": "omission", "label": "extent"}, {"doc_id": 5866486, "edit_id": 7, "question": "What are the specific benefits of vestibular rehabilitation for head trauma patients?", "category": "concept", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 0, "question": "What are the potential benefits of liraglutide on glucose and lipid metabolism disorder and adhesion molecule activation?", "category": "omission", "label": "consequence"}, {"doc_id": 5891985, "edit_id": 1, "question": "What are non-esterified free fatty acids (NEFA) and why are they considered harmful?", "category": "concept", "label": "concept"}, {"doc_id": 5891985, "edit_id": 2, "question": "What is soluble vascular cell adhesion molecule-1 (sVCAM-1) and why is it associated with blood vessel damage?", "category": "concept", "label": "concept"}, {"doc_id": 5891985, "edit_id": 3, "question": "How did liraglutide and metformin compare in reducing sVCAM-1 levels?", "category": "omission", "label": "comparison"}, {"doc_id": 5923799, "edit_id": 0, "question": "What was the purpose of the study described in the text?", "category": "omission", "label": "cause"}, {"doc_id": 5923799, "edit_id": 1, "question": "How many children participated in the study, and how were they assigned to different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 2, "question": "How long did the Taekwondo training last, and how often did the participants attend the sessions?", "category": "concept", "label": "extent"}, {"doc_id": 5923799, "edit_id": 3, "question": "What specific test was used to measure balance, and was the improvement in balance statistically significant?", "category": "concept", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 4, "question": "What specific sub-variables of mood and cognitive function were measured, and were the results statistically significant?", "category": "omission", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 5, "question": "What specific sub-variables of sociability were measured, and were the results statistically significant?", "category": "omission", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 6, "question": "What were the conclusions of the study, and what do they imply for the effectiveness of Taekwondo training?", "category": "omission", "label": "consequence"}, {"doc_id": 5966460, "edit_id": 0, "question": "What is the purpose of the study and what type of microbicides are being tested?", "category": "omission", "label": "cause"}, {"doc_id": 5966460, "edit_id": 1, "question": "Why are in vivo studies necessary for the development of microbicides?", "category": "concept", "label": "cause"}, {"doc_id": 5966460, "edit_id": 2, "question": "What was the study design and how many animals were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5966460, "edit_id": 3, "question": "What specific proteins were analyzed in the study and how did the researchers determine that the GRFT gel did not significantly change protein levels?", "category": "concept", "label": "procedural"}, {"doc_id": 5966460, "edit_id": 4, "question": "What effects did the placebo formulations have on proteins?", "category": "omission", "label": "consequence"}, {"doc_id": 5966460, "edit_id": 5, "question": "What specific microbial taxa were increased in the HEC-GRFT gel and how did the researchers determine that the increase was statistically significant?", "category": "concept", "label": "procedural"}, {"doc_id": 5966460, "edit_id": 6, "question": "What effects did the placebo formulations have on proteins at baseline?", "category": "omission", "label": "consequence"}, {"doc_id": 5966460, "edit_id": 7, "question": "What are the implications of the study's results for the development of microbicides and what potential risks are associated with their use?", "category": "concept", "label": "consequence"}, {"doc_id": 5976307, "edit_id": 0, "question": "What is the Partial Mayo Score and how does it relate to the study?", "category": "omission", "label": "concept"}, {"doc_id": 5976307, "edit_id": 1, "question": "What is midazolam and how does it relate to etomidate in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5976307, "edit_id": 2, "question": "What is midazolam and how does it relate to propofol in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5976307, "edit_id": 3, "question": "What was the incidence of cardiopulmonary adverse events in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5976307, "edit_id": 4, "question": "What specific heart and lung-related issues occurred in the study?", "category": "omission", "label": "example"}, {"doc_id": 5976307, "edit_id": 5, "question": "What statistical analysis was used in the study and what were the results?", "category": "omission", "label": "procedural"}, {"doc_id": 5976307, "edit_id": 6, "question": "What is the ASA score and how does it relate to the study?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 0, "question": "What is the prevalence of prediabetes in the US population, and what is the age distribution of individuals with prediabetes?", "category": "omission", "label": "extent"}, {"doc_id": 5976501, "edit_id": 1, "question": "What specific lifestyle changes are involved in lifestyle modification for prediabetes?", "category": "concept", "label": "example"}, {"doc_id": 5976501, "edit_id": 2, "question": "What measure of disease activity was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 3, "question": "What is 5-ALA and how does it work?", "category": "concept", "label": "concept"}, {"doc_id": 5976501, "edit_id": 4, "question": "What software was used for statistical analysis in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 5, "question": "Was a literature review conducted to investigate the relationship between 5-ALA and mood and coping ability?", "category": "omission", "label": "verification"}, {"doc_id": 5976501, "edit_id": 6, "question": "What specific measures of effort were used in the study, and what was the dose-dependent relationship between 5-ALA intake and effort?", "category": "concept", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 0, "question": "What type of tonsillitis was studied in the research?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 1, "question": "How was the severity of the disease measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 2, "question": "What was the specific technique used for tonsil ablation in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 3, "question": "What type of laser was used for tonsil ablation in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 4, "question": "How long did the procedure take?", "category": "omission", "label": "extent"}, {"doc_id": 5985618, "edit_id": 5, "question": "What was the significance level of the results?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 0, "question": "What are the two conditions associated with aging that the study aims to address?", "category": "omission", "label": "concept"}, {"doc_id": 5986443, "edit_id": 1, "question": "What are the two strategies that may contribute to health improvements in older adults, according to the study?", "category": "omission", "label": "example"}, {"doc_id": 5986443, "edit_id": 2, "question": "How were the participants assigned to different groups in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5986443, "edit_id": 3, "question": "What statistical analysis was used in the study to analyze the data?", "category": "concept", "label": "procedural"}, {"doc_id": 5986443, "edit_id": 4, "question": "How long did the resistance training program last, and how often was it performed?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 5, "question": "What outcomes were measured in the study to assess the effectiveness of the intervention?", "category": "omission", "label": "procedural"}, {"doc_id": 5986443, "edit_id": 6, "question": "What were the specific results of the study in terms of the time vs. group interaction and the increases in SMM, strength, and the 10-m walk test?", "category": "omission", "label": "consequence"}, {"doc_id": 65514, "edit_id": 0, "question": "Where was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 65514, "edit_id": 1, "question": "What is the Partial Mayo Score?", "category": "omission", "label": "concept"}, {"doc_id": 65514, "edit_id": 2, "question": "What is considered low vitamin D levels?", "category": "concept", "label": "concept"}, {"doc_id": 65514, "edit_id": 3, "question": "What is the Short IBD Questionnaire (SIBDQ)?", "category": "concept", "label": "concept"}, {"doc_id": 65514, "edit_id": 4, "question": "What was the study design?", "category": "omission", "label": "concept"}, {"doc_id": 65514, "edit_id": 5, "question": "What was the dosage and administration method of the drugs?", "category": "omission", "label": "procedural"}, {"doc_id": 65514, "edit_id": 6, "question": "What type of cholesterol was measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 65514, "edit_id": 7, "question": "How often were blood samples collected?", "category": "omission", "label": "extent"}, {"doc_id": 65514, "edit_id": 8, "question": "What was the outcome of the study?", "category": "omission", "label": "consequence"}]